id	sid	tid	token	lemma	pos
work_nlc445pqs5hzxelntsxu5niqrq	1	1	untitled	untitled	JJ
work_nlc445pqs5hzxelntsxu5niqrq	1	2	LE	LE	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	3	JOURNAL	JOURNAL	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	4	CANADIEN	CANADIEN	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	5	DES	DES	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	6	SCIENCES	SCIENCES	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	7	NEUROLOGIQUES	NEUROLOGIQUES	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	8	LETTER	LETTER	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	9	TO	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	1	10	THE	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	1	11	EDITOR	EDITOR	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	12	TO	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	1	13	THE	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	1	14	EDITOR	EDITOR	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	15	SAMHD1	SAMHD1	.
work_nlc445pqs5hzxelntsxu5niqrq	1	16	MUTATIONS	mutation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	1	17	ARE	are	VBP
work_nlc445pqs5hzxelntsxu5niqrq	1	18	ALSO	also	RB
work_nlc445pqs5hzxelntsxu5niqrq	1	19	RESPONSIBLE	responsible	VBP
work_nlc445pqs5hzxelntsxu5niqrq	1	20	FOR	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	1	21	AICARDI	AICARDI	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	22	–	–	:
work_nlc445pqs5hzxelntsxu5niqrq	1	23	GOUTIÈRES	GOUTIÈRES	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	24	IN	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	1	25	THE	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	1	26	CREE	cree	JJ
work_nlc445pqs5hzxelntsxu5niqrq	1	27	POPULATION	POPULATION	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	28	Keywords	Keywords	NNPS
work_nlc445pqs5hzxelntsxu5niqrq	1	29	:	:	:
work_nlc445pqs5hzxelntsxu5niqrq	1	30	Encephalopathy	Encephalopathy	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	31	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	1	32	Aicardi	Aicardi	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	33	–	–	:
work_nlc445pqs5hzxelntsxu5niqrq	1	34	Goutières	Goutières	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	35	syndrome	syndrome	NN
work_nlc445pqs5hzxelntsxu5niqrq	1	36	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	1	37	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	38	encephalitis	encephalitis	JJ
work_nlc445pqs5hzxelntsxu5niqrq	1	39	Aicardi	Aicardi	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	40	–	–	:
work_nlc445pqs5hzxelntsxu5niqrq	1	41	Goutières	Goutières	NNP
work_nlc445pqs5hzxelntsxu5niqrq	1	42	syndrome	syndrome	NN
work_nlc445pqs5hzxelntsxu5niqrq	1	43	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	1	44	AGS	ags	NN
work_nlc445pqs5hzxelntsxu5niqrq	1	45	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	1	46	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	1	47	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	1	48	progressive	progressive	JJ
work_nlc445pqs5hzxelntsxu5niqrq	1	49	inflammatory	inflammatory	JJ
work_nlc445pqs5hzxelntsxu5niqrq	1	50	encephalopathy	encephalopathy	NN
work_nlc445pqs5hzxelntsxu5niqrq	1	51	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	1	52	multi	multi	JJ
work_nlc445pqs5hzxelntsxu5niqrq	1	53	-	-	JJ
work_nlc445pqs5hzxelntsxu5niqrq	1	54	organ	organ	JJ
work_nlc445pqs5hzxelntsxu5niqrq	1	55	involvement	involvement	NN
work_nlc445pqs5hzxelntsxu5niqrq	1	56	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	2	1	There	there	EX
work_nlc445pqs5hzxelntsxu5niqrq	2	2	are	be	VBP
work_nlc445pqs5hzxelntsxu5niqrq	2	3	seven	seven	CD
work_nlc445pqs5hzxelntsxu5niqrq	2	4	genes	gene	NNS
work_nlc445pqs5hzxelntsxu5niqrq	2	5	known	know	VBN
work_nlc445pqs5hzxelntsxu5niqrq	2	6	to	to	TO
work_nlc445pqs5hzxelntsxu5niqrq	2	7	be	be	VB
work_nlc445pqs5hzxelntsxu5niqrq	2	8	responsible	responsible	JJ
work_nlc445pqs5hzxelntsxu5niqrq	2	9	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	2	10	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	2	11	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	2	12	TREX1	TREX1	NNS
work_nlc445pqs5hzxelntsxu5niqrq	2	13	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	2	14	RNASEH2A	RNASEH2A	NNP
work_nlc445pqs5hzxelntsxu5niqrq	2	15	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	2	16	RNASEH2B	RNASEH2B	NNP
work_nlc445pqs5hzxelntsxu5niqrq	2	17	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	2	18	RNASEH2C	RNASEH2C	NNP
work_nlc445pqs5hzxelntsxu5niqrq	2	19	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	2	20	SAMHD1	SAMHD1	NNP
work_nlc445pqs5hzxelntsxu5niqrq	2	21	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	2	22	ADAR	ADAR	NNP
work_nlc445pqs5hzxelntsxu5niqrq	2	23	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	2	24	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	2	25	IFIH1	ifih1	PRP
work_nlc445pqs5hzxelntsxu5niqrq	2	26	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	2	27	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	3	1	The	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	3	2	most	most	RBS
work_nlc445pqs5hzxelntsxu5niqrq	3	3	common	common	JJ
work_nlc445pqs5hzxelntsxu5niqrq	3	4	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	3	5	TREX1	TREX1	NNS
work_nlc445pqs5hzxelntsxu5niqrq	3	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	3	7	typically	typically	RB
work_nlc445pqs5hzxelntsxu5niqrq	3	8	presenting	present	VBG
work_nlc445pqs5hzxelntsxu5niqrq	3	9	as	as	IN
work_nlc445pqs5hzxelntsxu5niqrq	3	10	neonatal	neonatal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	3	11	encephalopathy	encephalopathy	NN
work_nlc445pqs5hzxelntsxu5niqrq	3	12	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	3	13	cystic	cystic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	3	14	leukoencephalopathy	leukoencephalopathy	NN
work_nlc445pqs5hzxelntsxu5niqrq	3	15	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	3	16	calcifications	calcification	NNS
work_nlc445pqs5hzxelntsxu5niqrq	3	17	on	on	IN
work_nlc445pqs5hzxelntsxu5niqrq	3	18	brain	brain	NN
work_nlc445pqs5hzxelntsxu5niqrq	3	19	imaging	imaging	NN
work_nlc445pqs5hzxelntsxu5niqrq	3	20	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	4	1	Affected	affect	VBN
work_nlc445pqs5hzxelntsxu5niqrq	4	2	infants	infant	NNS
work_nlc445pqs5hzxelntsxu5niqrq	4	3	may	may	MD
work_nlc445pqs5hzxelntsxu5niqrq	4	4	present	present	VB
work_nlc445pqs5hzxelntsxu5niqrq	4	5	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	4	6	hepatosplenomegaly	hepatosplenomegaly	NNP
work_nlc445pqs5hzxelntsxu5niqrq	4	7	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	4	8	transaminitis	transaminitis	NN
work_nlc445pqs5hzxelntsxu5niqrq	4	9	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	4	10	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	4	11	thrombocytopenia	thrombocytopenia	NNP
work_nlc445pqs5hzxelntsxu5niqrq	4	12	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	4	13	are	be	VBP
work_nlc445pqs5hzxelntsxu5niqrq	4	14	often	often	RB
work_nlc445pqs5hzxelntsxu5niqrq	4	15	presumed	presume	VBN
work_nlc445pqs5hzxelntsxu5niqrq	4	16	to	to	TO
work_nlc445pqs5hzxelntsxu5niqrq	4	17	have	have	VB
work_nlc445pqs5hzxelntsxu5niqrq	4	18	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	4	19	congenital	congenital	JJ
work_nlc445pqs5hzxelntsxu5niqrq	4	20	viral	viral	JJ
work_nlc445pqs5hzxelntsxu5niqrq	4	21	infection	infection	NN
work_nlc445pqs5hzxelntsxu5niqrq	4	22	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	5	1	However	however	RB
work_nlc445pqs5hzxelntsxu5niqrq	5	2	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	5	3	many	many	JJ
work_nlc445pqs5hzxelntsxu5niqrq	5	4	children	child	NNS
work_nlc445pqs5hzxelntsxu5niqrq	5	5	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	5	6	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	5	7	present	present	NN
work_nlc445pqs5hzxelntsxu5niqrq	5	8	within	within	IN
work_nlc445pqs5hzxelntsxu5niqrq	5	9	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	5	10	first	first	JJ
work_nlc445pqs5hzxelntsxu5niqrq	5	11	weeks	week	NNS
work_nlc445pqs5hzxelntsxu5niqrq	5	12	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	5	13	life	life	NN
work_nlc445pqs5hzxelntsxu5niqrq	5	14	following	follow	VBG
work_nlc445pqs5hzxelntsxu5niqrq	5	15	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	5	16	normal	normal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	5	17	neonatal	neonatal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	5	18	period	period	NN
work_nlc445pqs5hzxelntsxu5niqrq	5	19	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	6	1	Clinical	clinical	JJ
work_nlc445pqs5hzxelntsxu5niqrq	6	2	manifestations	manifestation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	6	3	include	include	VBP
work_nlc445pqs5hzxelntsxu5niqrq	6	4	developmental	developmental	JJ
work_nlc445pqs5hzxelntsxu5niqrq	6	5	regression	regression	NN
work_nlc445pqs5hzxelntsxu5niqrq	6	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	6	7	difficulty	difficulty	NN
work_nlc445pqs5hzxelntsxu5niqrq	6	8	feeding	feeding	NN
work_nlc445pqs5hzxelntsxu5niqrq	6	9	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	6	10	micro-	micro-	NNP
work_nlc445pqs5hzxelntsxu5niqrq	6	11	cephaly	cephaly	NNP
work_nlc445pqs5hzxelntsxu5niqrq	6	12	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	6	13	spasticity	spasticity	NN
work_nlc445pqs5hzxelntsxu5niqrq	6	14	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	6	15	seizures	seizure	NNS
work_nlc445pqs5hzxelntsxu5niqrq	6	16	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	6	17	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	6	18	sterile	sterile	JJ
work_nlc445pqs5hzxelntsxu5niqrq	6	19	pyrexias	pyrexia	NNS
work_nlc445pqs5hzxelntsxu5niqrq	6	20	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	7	1	First	first	RB
work_nlc445pqs5hzxelntsxu5niqrq	7	2	described	describe	VBN
work_nlc445pqs5hzxelntsxu5niqrq	7	3	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	7	4	11	11	CD
work_nlc445pqs5hzxelntsxu5niqrq	7	5	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	7	6	children	child	NNS
work_nlc445pqs5hzxelntsxu5niqrq	7	7	from	from	IN
work_nlc445pqs5hzxelntsxu5niqrq	7	8	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	7	9	Northern	Northern	NNP
work_nlc445pqs5hzxelntsxu5niqrq	7	10	Quebec	Quebec	NNP
work_nlc445pqs5hzxelntsxu5niqrq	7	11	village	village	NN
work_nlc445pqs5hzxelntsxu5niqrq	7	12	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	7	13	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	7	14	encephalitis	encephalitis	NNP
work_nlc445pqs5hzxelntsxu5niqrq	7	15	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	7	16	thought	think	VBN
work_nlc445pqs5hzxelntsxu5niqrq	7	17	to	to	TO
work_nlc445pqs5hzxelntsxu5niqrq	7	18	be	be	VB
work_nlc445pqs5hzxelntsxu5niqrq	7	19	an	an	DT
work_nlc445pqs5hzxelntsxu5niqrq	7	20	immune	immune	JJ
work_nlc445pqs5hzxelntsxu5niqrq	7	21	condition	condition	NN
work_nlc445pqs5hzxelntsxu5niqrq	7	22	possibly	possibly	RB
work_nlc445pqs5hzxelntsxu5niqrq	7	23	triggered	trigger	VBN
work_nlc445pqs5hzxelntsxu5niqrq	7	24	by	by	IN
work_nlc445pqs5hzxelntsxu5niqrq	7	25	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	7	26	prenatal	prenatal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	7	27	viral	viral	NN
work_nlc445pqs5hzxelntsxu5niqrq	7	28	or	or	CC
work_nlc445pqs5hzxelntsxu5niqrq	7	29	retroviral	retroviral	JJ
work_nlc445pqs5hzxelntsxu5niqrq	7	30	infection	infection	NN
work_nlc445pqs5hzxelntsxu5niqrq	7	31	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	7	32	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	7	33	genetically	genetically	RB
work_nlc445pqs5hzxelntsxu5niqrq	7	34	predisposed	predispose	VBN
work_nlc445pqs5hzxelntsxu5niqrq	7	35	population.1	population.1	NNP
work_nlc445pqs5hzxelntsxu5niqrq	7	36	Currently	currently	RB
work_nlc445pqs5hzxelntsxu5niqrq	7	37	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	7	38	only	only	RB
work_nlc445pqs5hzxelntsxu5niqrq	7	39	TREX1	trex1	NN
work_nlc445pqs5hzxelntsxu5niqrq	7	40	mutations	mutation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	7	41	have	have	VBP
work_nlc445pqs5hzxelntsxu5niqrq	7	42	been	be	VBN
work_nlc445pqs5hzxelntsxu5niqrq	7	43	implicated	implicate	VBN
work_nlc445pqs5hzxelntsxu5niqrq	7	44	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	7	45	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	7	46	encephalitis.2	encephalitis.2	CC
work_nlc445pqs5hzxelntsxu5niqrq	7	47	A	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	7	48	pathogenic	pathogenic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	7	49	variant	variant	JJ
work_nlc445pqs5hzxelntsxu5niqrq	7	50	affecting	affecting	NN
work_nlc445pqs5hzxelntsxu5niqrq	7	51	SAMHD1	samhd1	NN
work_nlc445pqs5hzxelntsxu5niqrq	7	52	has	have	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	7	53	not	not	RB
work_nlc445pqs5hzxelntsxu5niqrq	7	54	been	be	VBN
work_nlc445pqs5hzxelntsxu5niqrq	7	55	described	describe	VBN
work_nlc445pqs5hzxelntsxu5niqrq	7	56	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	7	57	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	7	58	children	child	NNS
work_nlc445pqs5hzxelntsxu5niqrq	7	59	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	8	1	We	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	8	2	report	report	VBP
work_nlc445pqs5hzxelntsxu5niqrq	8	3	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	8	4	case	case	NN
work_nlc445pqs5hzxelntsxu5niqrq	8	5	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	8	6	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	8	7	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	8	8	boy	boy	NN
work_nlc445pqs5hzxelntsxu5niqrq	8	9	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	8	10	phenotypic	phenotypic	NN
work_nlc445pqs5hzxelntsxu5niqrq	8	11	severe	severe	JJ
work_nlc445pqs5hzxelntsxu5niqrq	8	12	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	8	13	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	8	14	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	8	15	homozygous	homozygous	JJ
work_nlc445pqs5hzxelntsxu5niqrq	8	16	SAMHD1	samhd1	NN
work_nlc445pqs5hzxelntsxu5niqrq	8	17	mutation	mutation	NN
work_nlc445pqs5hzxelntsxu5niqrq	8	18	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	9	1	Consent	consent	NN
work_nlc445pqs5hzxelntsxu5niqrq	9	2	was	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	9	3	obtained	obtain	VBN
work_nlc445pqs5hzxelntsxu5niqrq	9	4	from	from	IN
work_nlc445pqs5hzxelntsxu5niqrq	9	5	his	-PRON-	PRP$
work_nlc445pqs5hzxelntsxu5niqrq	9	6	biological	biological	JJ
work_nlc445pqs5hzxelntsxu5niqrq	9	7	parents	parent	NNS
work_nlc445pqs5hzxelntsxu5niqrq	9	8	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	10	1	The	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	10	2	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	10	3	phenotype	phenotype	NN
work_nlc445pqs5hzxelntsxu5niqrq	10	4	due	due	IN
work_nlc445pqs5hzxelntsxu5niqrq	10	5	to	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	10	6	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	10	7	common	common	JJ
work_nlc445pqs5hzxelntsxu5niqrq	10	8	muta-	muta-	NN
work_nlc445pqs5hzxelntsxu5niqrq	10	9	tion	tion	NN
work_nlc445pqs5hzxelntsxu5niqrq	10	10	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	10	11	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	10	12	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	10	13	population	population	NN
work_nlc445pqs5hzxelntsxu5niqrq	10	14	has	have	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	10	15	traditionally	traditionally	RB
work_nlc445pqs5hzxelntsxu5niqrq	10	16	been	be	VBN
work_nlc445pqs5hzxelntsxu5niqrq	10	17	referred	refer	VBN
work_nlc445pqs5hzxelntsxu5niqrq	10	18	to	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	10	19	as	as	IN
work_nlc445pqs5hzxelntsxu5niqrq	10	20	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	10	21	encephalitis	encephalitis	RB
work_nlc445pqs5hzxelntsxu5niqrq	10	22	but	but	CC
work_nlc445pqs5hzxelntsxu5niqrq	10	23	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	10	24	allelic	allelic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	10	25	to	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	10	26	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	10	27	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	10	28	some	some	DT
work_nlc445pqs5hzxelntsxu5niqrq	10	29	patients	patient	NNS
work_nlc445pqs5hzxelntsxu5niqrq	10	30	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	11	1	Therefore	therefore	RB
work_nlc445pqs5hzxelntsxu5niqrq	11	2	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	11	3	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	11	4	encephalitis	encephalitis	NNP
work_nlc445pqs5hzxelntsxu5niqrq	11	5	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	11	6	likely	likely	JJ
work_nlc445pqs5hzxelntsxu5niqrq	11	7	part	part	NN
work_nlc445pqs5hzxelntsxu5niqrq	11	8	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	11	9	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	11	10	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	11	11	spectrum	spectrum	NN
work_nlc445pqs5hzxelntsxu5niqrq	11	12	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	11	13	disorders	disorder	NNS
work_nlc445pqs5hzxelntsxu5niqrq	11	14	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	12	1	Our	-PRON-	PRP$
work_nlc445pqs5hzxelntsxu5niqrq	12	2	patient	patient	NN
work_nlc445pqs5hzxelntsxu5niqrq	12	3	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	12	4	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	12	5	5-year	5-year	CD
work_nlc445pqs5hzxelntsxu5niqrq	12	6	-	-	HYPH
work_nlc445pqs5hzxelntsxu5niqrq	12	7	old	old	JJ
work_nlc445pqs5hzxelntsxu5niqrq	12	8	boy	boy	NN
work_nlc445pqs5hzxelntsxu5niqrq	12	9	born	bear	VBN
work_nlc445pqs5hzxelntsxu5niqrq	12	10	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	12	11	term	term	NN
work_nlc445pqs5hzxelntsxu5niqrq	12	12	by	by	IN
work_nlc445pqs5hzxelntsxu5niqrq	12	13	caesarean	caesarean	JJ
work_nlc445pqs5hzxelntsxu5niqrq	12	14	section	section	NN
work_nlc445pqs5hzxelntsxu5niqrq	12	15	to	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	12	16	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	12	17	healthy	healthy	JJ
work_nlc445pqs5hzxelntsxu5niqrq	12	18	gravida-5	gravida-5	NNP
work_nlc445pqs5hzxelntsxu5niqrq	12	19	/	/	SYM
work_nlc445pqs5hzxelntsxu5niqrq	12	20	para-5	para-5	NNP
work_nlc445pqs5hzxelntsxu5niqrq	12	21	mother	mother	NN
work_nlc445pqs5hzxelntsxu5niqrq	12	22	after	after	IN
work_nlc445pqs5hzxelntsxu5niqrq	12	23	an	an	DT
work_nlc445pqs5hzxelntsxu5niqrq	12	24	uncompli-	uncompli-	NN
work_nlc445pqs5hzxelntsxu5niqrq	12	25	cated	cat	VBD
work_nlc445pqs5hzxelntsxu5niqrq	12	26	pregnancy	pregnancy	NN
work_nlc445pqs5hzxelntsxu5niqrq	12	27	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	12	28	delivery	delivery	NN
work_nlc445pqs5hzxelntsxu5niqrq	12	29	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	13	1	Prenatal	Prenatal	NNP
work_nlc445pqs5hzxelntsxu5niqrq	13	2	ultrasounds	ultrasound	NNS
work_nlc445pqs5hzxelntsxu5niqrq	13	3	were	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	13	4	normal	normal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	13	5	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	14	1	He	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	14	2	required	require	VBD
work_nlc445pqs5hzxelntsxu5niqrq	14	3	no	no	DT
work_nlc445pqs5hzxelntsxu5niqrq	14	4	resuscitation	resuscitation	NN
work_nlc445pqs5hzxelntsxu5niqrq	14	5	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	14	6	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	14	7	there	there	EX
work_nlc445pqs5hzxelntsxu5niqrq	14	8	were	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	14	9	no	no	DT
work_nlc445pqs5hzxelntsxu5niqrq	14	10	postnatal	postnatal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	14	11	complications	complication	NNS
work_nlc445pqs5hzxelntsxu5niqrq	14	12	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	15	1	To	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	15	2	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	15	3	parents	parent	NNS
work_nlc445pqs5hzxelntsxu5niqrq	15	4	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	15	5	he	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	15	6	appeared	appear	VBD
work_nlc445pqs5hzxelntsxu5niqrq	15	7	developmentally	developmentally	RB
work_nlc445pqs5hzxelntsxu5niqrq	15	8	nor-	nor-	IN
work_nlc445pqs5hzxelntsxu5niqrq	15	9	mal	mal	NNP
work_nlc445pqs5hzxelntsxu5niqrq	15	10	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	15	11	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	15	12	first	first	JJ
work_nlc445pqs5hzxelntsxu5niqrq	15	13	2	2	CD
work_nlc445pqs5hzxelntsxu5niqrq	15	14	months	month	NNS
work_nlc445pqs5hzxelntsxu5niqrq	15	15	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	15	16	life	life	NN
work_nlc445pqs5hzxelntsxu5niqrq	15	17	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	15	18	normal	normal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	15	19	head	head	NN
work_nlc445pqs5hzxelntsxu5niqrq	15	20	control	control	NN
work_nlc445pqs5hzxelntsxu5niqrq	15	21	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	15	22	feeding	feeding	NN
work_nlc445pqs5hzxelntsxu5niqrq	15	23	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	16	1	However	however	RB
work_nlc445pqs5hzxelntsxu5niqrq	16	2	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	16	3	he	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	16	4	never	never	RB
work_nlc445pqs5hzxelntsxu5niqrq	16	5	learned	learn	VBD
work_nlc445pqs5hzxelntsxu5niqrq	16	6	to	to	TO
work_nlc445pqs5hzxelntsxu5niqrq	16	7	smile	smile	VB
work_nlc445pqs5hzxelntsxu5niqrq	16	8	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	16	9	coo	coo	NN
work_nlc445pqs5hzxelntsxu5niqrq	16	10	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	16	11	or	or	CC
work_nlc445pqs5hzxelntsxu5niqrq	16	12	reach	reach	VB
work_nlc445pqs5hzxelntsxu5niqrq	16	13	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	16	14	objects	object	NNS
work_nlc445pqs5hzxelntsxu5niqrq	16	15	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	17	1	Between	between	IN
work_nlc445pqs5hzxelntsxu5niqrq	17	2	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	17	3	age	age	NN
work_nlc445pqs5hzxelntsxu5niqrq	17	4	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	17	5	2	2	CD
work_nlc445pqs5hzxelntsxu5niqrq	17	6	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	17	7	3	3	CD
work_nlc445pqs5hzxelntsxu5niqrq	17	8	months	month	NNS
work_nlc445pqs5hzxelntsxu5niqrq	17	9	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	17	10	he	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	17	11	had	have	VBD
work_nlc445pqs5hzxelntsxu5niqrq	17	12	an	an	DT
work_nlc445pqs5hzxelntsxu5niqrq	17	13	arrest	arrest	NN
work_nlc445pqs5hzxelntsxu5niqrq	17	14	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	17	15	gross	gross	JJ
work_nlc445pqs5hzxelntsxu5niqrq	17	16	motor	motor	NN
work_nlc445pqs5hzxelntsxu5niqrq	17	17	development	development	NN
work_nlc445pqs5hzxelntsxu5niqrq	17	18	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	17	19	lost	lose	VBD
work_nlc445pqs5hzxelntsxu5niqrq	17	20	head	head	NN
work_nlc445pqs5hzxelntsxu5niqrq	17	21	control	control	NN
work_nlc445pqs5hzxelntsxu5niqrq	17	22	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	18	1	He	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	18	2	developed	develop	VBD
work_nlc445pqs5hzxelntsxu5niqrq	18	3	spastic	spastic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	18	4	quadriplegia	quadriplegia	NN
work_nlc445pqs5hzxelntsxu5niqrq	18	5	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	18	6	opisthotonus	opisthotonus	NN
work_nlc445pqs5hzxelntsxu5niqrq	18	7	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	19	1	At	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	19	2	6	6	CD
work_nlc445pqs5hzxelntsxu5niqrq	19	3	months	month	NNS
work_nlc445pqs5hzxelntsxu5niqrq	19	4	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	19	5	he	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	19	6	required	require	VBD
work_nlc445pqs5hzxelntsxu5niqrq	19	7	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	19	8	gastrostomy	gastrostomy	NN
work_nlc445pqs5hzxelntsxu5niqrq	19	9	tube	tube	NN
work_nlc445pqs5hzxelntsxu5niqrq	19	10	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	19	11	feeding	feeding	NN
work_nlc445pqs5hzxelntsxu5niqrq	19	12	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	19	13	through	through	IN
work_nlc445pqs5hzxelntsxu5niqrq	19	14	which	which	WDT
work_nlc445pqs5hzxelntsxu5niqrq	19	15	he	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	19	16	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	19	17	now	now	RB
work_nlc445pqs5hzxelntsxu5niqrq	19	18	exclusively	exclusively	RB
work_nlc445pqs5hzxelntsxu5niqrq	19	19	fed	feed	VBN
work_nlc445pqs5hzxelntsxu5niqrq	19	20	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	20	1	At	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	20	2	12	12	CD
work_nlc445pqs5hzxelntsxu5niqrq	20	3	months	month	NNS
work_nlc445pqs5hzxelntsxu5niqrq	20	4	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	20	5	he	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	20	6	developed	develop	VBD
work_nlc445pqs5hzxelntsxu5niqrq	20	7	myoclonic	myoclonic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	20	8	seizures	seizure	NNS
work_nlc445pqs5hzxelntsxu5niqrq	20	9	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	21	1	He	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	21	2	was	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	21	3	diagnosed	diagnose	VBN
work_nlc445pqs5hzxelntsxu5niqrq	21	4	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	21	5	glaucoma	glaucoma	NN
work_nlc445pqs5hzxelntsxu5niqrq	21	6	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	21	7	2	2	CD
work_nlc445pqs5hzxelntsxu5niqrq	21	8	years	year	NNS
work_nlc445pqs5hzxelntsxu5niqrq	21	9	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	21	10	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	21	11	cortically	cortically	RB
work_nlc445pqs5hzxelntsxu5niqrq	21	12	blind	blind	JJ
work_nlc445pqs5hzxelntsxu5niqrq	21	13	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	22	1	He	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	22	2	has	have	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	22	3	several	several	JJ
work_nlc445pqs5hzxelntsxu5niqrq	22	4	hospital	hospital	NN
work_nlc445pqs5hzxelntsxu5niqrq	22	5	admissions	admission	NNS
work_nlc445pqs5hzxelntsxu5niqrq	22	6	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	22	7	aspiration	aspiration	NN
work_nlc445pqs5hzxelntsxu5niqrq	22	8	pneumonia	pneumonia	NN
work_nlc445pqs5hzxelntsxu5niqrq	22	9	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	22	10	status	status	NN
work_nlc445pqs5hzxelntsxu5niqrq	22	11	epilepticus	epilepticus	NN
work_nlc445pqs5hzxelntsxu5niqrq	22	12	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	23	1	Other	other	JJ
work_nlc445pqs5hzxelntsxu5niqrq	23	2	issues	issue	NNS
work_nlc445pqs5hzxelntsxu5niqrq	23	3	included	include	VBD
work_nlc445pqs5hzxelntsxu5niqrq	23	4	hypertension	hypertension	NN
work_nlc445pqs5hzxelntsxu5niqrq	23	5	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	23	6	secundum	secundum	NN
work_nlc445pqs5hzxelntsxu5niqrq	23	7	atrial	atrial	JJ
work_nlc445pqs5hzxelntsxu5niqrq	23	8	septal	septal	NN
work_nlc445pqs5hzxelntsxu5niqrq	23	9	defect	defect	NN
work_nlc445pqs5hzxelntsxu5niqrq	23	10	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	23	11	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	23	12	recurrent	recurrent	JJ
work_nlc445pqs5hzxelntsxu5niqrq	23	13	fevers	fever	NNS
work_nlc445pqs5hzxelntsxu5niqrq	23	14	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	23	15	unknown	unknown	JJ
work_nlc445pqs5hzxelntsxu5niqrq	23	16	origin	origin	NN
work_nlc445pqs5hzxelntsxu5niqrq	23	17	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	24	1	Physical	physical	JJ
work_nlc445pqs5hzxelntsxu5niqrq	24	2	examination	examination	NN
work_nlc445pqs5hzxelntsxu5niqrq	24	3	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	24	4	3.5	3.5	CD
work_nlc445pqs5hzxelntsxu5niqrq	24	5	years	year	NNS
work_nlc445pqs5hzxelntsxu5niqrq	24	6	revealed	reveal	VBN
work_nlc445pqs5hzxelntsxu5niqrq	24	7	severe	severe	JJ
work_nlc445pqs5hzxelntsxu5niqrq	24	8	micro-	micro-	FW
work_nlc445pqs5hzxelntsxu5niqrq	24	9	cephaly	cephaly	NNP
work_nlc445pqs5hzxelntsxu5niqrq	24	10	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	24	11	<	<	XX
work_nlc445pqs5hzxelntsxu5niqrq	24	12	2	2	CD
work_nlc445pqs5hzxelntsxu5niqrq	24	13	%	%	NN
work_nlc445pqs5hzxelntsxu5niqrq	24	14	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	24	15	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	24	16	spastic	spastic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	24	17	quadriplegia	quadriplegia	NN
work_nlc445pqs5hzxelntsxu5niqrq	24	18	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	24	19	severe	severe	JJ
work_nlc445pqs5hzxelntsxu5niqrq	24	20	contractures	contracture	NNS
work_nlc445pqs5hzxelntsxu5niqrq	24	21	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	24	22	all	all	DT
work_nlc445pqs5hzxelntsxu5niqrq	24	23	limbs	limb	NNS
work_nlc445pqs5hzxelntsxu5niqrq	24	24	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	24	25	spontaneous	spontaneous	JJ
work_nlc445pqs5hzxelntsxu5niqrq	24	26	clonus	clonu	NNS
work_nlc445pqs5hzxelntsxu5niqrq	24	27	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	24	28	dystonic	dystonic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	24	29	posturing	posturing	NN
work_nlc445pqs5hzxelntsxu5niqrq	24	30	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	24	31	upgoing	upgoe	VBG
work_nlc445pqs5hzxelntsxu5niqrq	24	32	plantar	plantar	NN
work_nlc445pqs5hzxelntsxu5niqrq	24	33	responses	response	NNS
work_nlc445pqs5hzxelntsxu5niqrq	24	34	bilaterally	bilaterally	RB
work_nlc445pqs5hzxelntsxu5niqrq	24	35	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	24	36	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	24	37	hepatosplenomegaly	hepatosplenomegaly	NNP
work_nlc445pqs5hzxelntsxu5niqrq	24	38	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	25	1	He	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	25	2	demonstrated	demonstrate	VBD
work_nlc445pqs5hzxelntsxu5niqrq	25	3	small	small	JJ
work_nlc445pqs5hzxelntsxu5niqrq	25	4	violaceous	violaceous	JJ
work_nlc445pqs5hzxelntsxu5niqrq	25	5	palpable	palpable	JJ
work_nlc445pqs5hzxelntsxu5niqrq	25	6	lesions	lesion	NNS
work_nlc445pqs5hzxelntsxu5niqrq	25	7	on	on	IN
work_nlc445pqs5hzxelntsxu5niqrq	25	8	his	-PRON-	PRP$
work_nlc445pqs5hzxelntsxu5niqrq	25	9	nose	nose	NN
work_nlc445pqs5hzxelntsxu5niqrq	25	10	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	25	11	right	right	JJ
work_nlc445pqs5hzxelntsxu5niqrq	25	12	great	great	JJ
work_nlc445pqs5hzxelntsxu5niqrq	25	13	toe	toe	NN
work_nlc445pqs5hzxelntsxu5niqrq	25	14	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	26	1	Currently	currently	RB
work_nlc445pqs5hzxelntsxu5niqrq	26	2	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	26	3	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	26	4	age	age	NN
work_nlc445pqs5hzxelntsxu5niqrq	26	5	5	5	CD
work_nlc445pqs5hzxelntsxu5niqrq	26	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	26	7	he	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	26	8	smiles	smile	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	26	9	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	26	10	response	response	NN
work_nlc445pqs5hzxelntsxu5niqrq	26	11	to	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	26	12	his	-PRON-	PRP$
work_nlc445pqs5hzxelntsxu5niqrq	26	13	parents	parent	NNS
work_nlc445pqs5hzxelntsxu5niqrq	26	14	’	’	POS
work_nlc445pqs5hzxelntsxu5niqrq	26	15	voice	voice	NN
work_nlc445pqs5hzxelntsxu5niqrq	26	16	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	26	17	occasionally	occasionally	RB
work_nlc445pqs5hzxelntsxu5niqrq	26	18	coos	coo	NNS
work_nlc445pqs5hzxelntsxu5niqrq	26	19	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	26	20	but	but	CC
work_nlc445pqs5hzxelntsxu5niqrq	26	21	he	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	26	22	has	have	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	26	23	no	no	DT
work_nlc445pqs5hzxelntsxu5niqrq	26	24	spontaneous	spontaneous	JJ
work_nlc445pqs5hzxelntsxu5niqrq	26	25	movements	movement	NNS
work_nlc445pqs5hzxelntsxu5niqrq	26	26	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	27	1	He	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	27	2	continues	continue	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	27	3	to	to	TO
work_nlc445pqs5hzxelntsxu5niqrq	27	4	have	have	VB
work_nlc445pqs5hzxelntsxu5niqrq	27	5	intermittent	intermittent	JJ
work_nlc445pqs5hzxelntsxu5niqrq	27	6	fevers	fever	NNS
work_nlc445pqs5hzxelntsxu5niqrq	27	7	without	without	IN
work_nlc445pqs5hzxelntsxu5niqrq	27	8	infections	infection	NNS
work_nlc445pqs5hzxelntsxu5niqrq	27	9	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	28	1	His	-PRON-	PRP$
work_nlc445pqs5hzxelntsxu5niqrq	28	2	seizures	seizure	NNS
work_nlc445pqs5hzxelntsxu5niqrq	28	3	are	be	VBP
work_nlc445pqs5hzxelntsxu5niqrq	28	4	under	under	IN
work_nlc445pqs5hzxelntsxu5niqrq	28	5	control	control	NN
work_nlc445pqs5hzxelntsxu5niqrq	28	6	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	29	1	Both	both	DT
work_nlc445pqs5hzxelntsxu5niqrq	29	2	parents	parent	NNS
work_nlc445pqs5hzxelntsxu5niqrq	29	3	are	be	VBP
work_nlc445pqs5hzxelntsxu5niqrq	29	4	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	29	5	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	29	6	origin	origin	NN
work_nlc445pqs5hzxelntsxu5niqrq	29	7	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	29	8	reside	reside	VB
work_nlc445pqs5hzxelntsxu5niqrq	29	9	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	29	10	northeastern	northeastern	JJ
work_nlc445pqs5hzxelntsxu5niqrq	29	11	Ontario	Ontario	NNP
work_nlc445pqs5hzxelntsxu5niqrq	29	12	along	along	IN
work_nlc445pqs5hzxelntsxu5niqrq	29	13	James	James	NNP
work_nlc445pqs5hzxelntsxu5niqrq	29	14	Bay	Bay	NNP
work_nlc445pqs5hzxelntsxu5niqrq	29	15	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	29	16	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	29	17	are	be	VBP
work_nlc445pqs5hzxelntsxu5niqrq	29	18	from	from	IN
work_nlc445pqs5hzxelntsxu5niqrq	29	19	different	different	JJ
work_nlc445pqs5hzxelntsxu5niqrq	29	20	communities	community	NNS
work_nlc445pqs5hzxelntsxu5niqrq	29	21	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	30	1	The	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	30	2	mother	mother	NN
work_nlc445pqs5hzxelntsxu5niqrq	30	3	had	have	VBD
work_nlc445pqs5hzxelntsxu5niqrq	30	4	two	two	CD
work_nlc445pqs5hzxelntsxu5niqrq	30	5	male	male	JJ
work_nlc445pqs5hzxelntsxu5niqrq	30	6	cousins	cousin	NNS
work_nlc445pqs5hzxelntsxu5niqrq	30	7	via	via	IN
work_nlc445pqs5hzxelntsxu5niqrq	30	8	her	-PRON-	PRP$
work_nlc445pqs5hzxelntsxu5niqrq	30	9	maternal	maternal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	30	10	aunt	aunt	NN
work_nlc445pqs5hzxelntsxu5niqrq	30	11	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	30	12	developmental	developmental	JJ
work_nlc445pqs5hzxelntsxu5niqrq	30	13	delay	delay	NN
work_nlc445pqs5hzxelntsxu5niqrq	30	14	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	30	15	seizures	seizure	NNS
work_nlc445pqs5hzxelntsxu5niqrq	30	16	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	30	17	both	both	DT
work_nlc445pqs5hzxelntsxu5niqrq	30	18	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	30	19	whom	whom	WP
work_nlc445pqs5hzxelntsxu5niqrq	30	20	died	die	VBD
work_nlc445pqs5hzxelntsxu5niqrq	30	21	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	30	22	age	age	NN
work_nlc445pqs5hzxelntsxu5niqrq	30	23	8	8	CD
work_nlc445pqs5hzxelntsxu5niqrq	30	24	months	month	NNS
work_nlc445pqs5hzxelntsxu5niqrq	30	25	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	31	1	No	no	DT
work_nlc445pqs5hzxelntsxu5niqrq	31	2	other	other	JJ
work_nlc445pqs5hzxelntsxu5niqrq	31	3	family	family	NN
work_nlc445pqs5hzxelntsxu5niqrq	31	4	member	member	NN
work_nlc445pqs5hzxelntsxu5niqrq	31	5	has	have	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	31	6	had	have	VBN
work_nlc445pqs5hzxelntsxu5niqrq	31	7	neurological	neurological	JJ
work_nlc445pqs5hzxelntsxu5niqrq	31	8	issues	issue	NNS
work_nlc445pqs5hzxelntsxu5niqrq	31	9	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	32	1	Head	Head	NNP
work_nlc445pqs5hzxelntsxu5niqrq	32	2	MRI	MRI	NNP
work_nlc445pqs5hzxelntsxu5niqrq	32	3	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	32	4	age	age	NN
work_nlc445pqs5hzxelntsxu5niqrq	32	5	1	1	CD
work_nlc445pqs5hzxelntsxu5niqrq	32	6	year	year	NN
work_nlc445pqs5hzxelntsxu5niqrq	32	7	showed	show	VBD
work_nlc445pqs5hzxelntsxu5niqrq	32	8	tiny	tiny	JJ
work_nlc445pqs5hzxelntsxu5niqrq	32	9	periventricular	periventricular	JJ
work_nlc445pqs5hzxelntsxu5niqrq	32	10	white	white	NNP
work_nlc445pqs5hzxelntsxu5niqrq	32	11	matter	matter	NN
work_nlc445pqs5hzxelntsxu5niqrq	32	12	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	32	13	basal	basal	NNP
work_nlc445pqs5hzxelntsxu5niqrq	32	14	ganglia	ganglia	NNP
work_nlc445pqs5hzxelntsxu5niqrq	32	15	T1	T1	NNP
work_nlc445pqs5hzxelntsxu5niqrq	32	16	hyperintensities	hyperintensitie	NNS
work_nlc445pqs5hzxelntsxu5niqrq	32	17	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	32	18	Figure	figure	NN
work_nlc445pqs5hzxelntsxu5niqrq	32	19	1	1	CD
work_nlc445pqs5hzxelntsxu5niqrq	32	20	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	32	21	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	33	1	Findings	finding	NNS
work_nlc445pqs5hzxelntsxu5niqrq	33	2	on	on	IN
work_nlc445pqs5hzxelntsxu5niqrq	33	3	T2-weighted	t2-weighte	VBN
work_nlc445pqs5hzxelntsxu5niqrq	33	4	imaging	imaging	NN
work_nlc445pqs5hzxelntsxu5niqrq	33	5	included	include	VBN
work_nlc445pqs5hzxelntsxu5niqrq	33	6	frontal	frontal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	33	7	predominant	predominant	NN
work_nlc445pqs5hzxelntsxu5niqrq	33	8	periven-	periven-	NN
work_nlc445pqs5hzxelntsxu5niqrq	33	9	tricular	tricular	JJ
work_nlc445pqs5hzxelntsxu5niqrq	33	10	hyperintensities	hyperintensitie	NNS
work_nlc445pqs5hzxelntsxu5niqrq	33	11	extending	extend	VBG
work_nlc445pqs5hzxelntsxu5niqrq	33	12	into	into	IN
work_nlc445pqs5hzxelntsxu5niqrq	33	13	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	33	14	subcortical	subcortical	JJ
work_nlc445pqs5hzxelntsxu5niqrq	33	15	U	u	NN
work_nlc445pqs5hzxelntsxu5niqrq	33	16	-	-	HYPH
work_nlc445pqs5hzxelntsxu5niqrq	33	17	fibers	fiber	NNS
work_nlc445pqs5hzxelntsxu5niqrq	33	18	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	33	19	anterior	anterior	JJ
work_nlc445pqs5hzxelntsxu5niqrq	33	20	temporal	temporal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	33	21	lobe	lobe	NNP
work_nlc445pqs5hzxelntsxu5niqrq	33	22	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	33	23	bifrontal	bifrontal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	33	24	subcortical	subcortical	JJ
work_nlc445pqs5hzxelntsxu5niqrq	33	25	cysts	cyst	NNS
work_nlc445pqs5hzxelntsxu5niqrq	33	26	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	33	27	frontal	frontal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	33	28	encephalocele	encephalocele	NNP
work_nlc445pqs5hzxelntsxu5niqrq	33	29	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	33	30	cavum	cavum	VB
work_nlc445pqs5hzxelntsxu5niqrq	33	31	septum	septum	NN
work_nlc445pqs5hzxelntsxu5niqrq	33	32	pellucidum	pellucidum	NN
work_nlc445pqs5hzxelntsxu5niqrq	33	33	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	33	34	abnormal	abnormal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	33	35	myelination	myelination	NN
work_nlc445pqs5hzxelntsxu5niqrq	33	36	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	33	37	external	external	JJ
work_nlc445pqs5hzxelntsxu5niqrq	33	38	capsules	capsule	NNS
work_nlc445pqs5hzxelntsxu5niqrq	33	39	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	33	40	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	33	41	internal	internal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	33	42	capsule	capsule	NN
work_nlc445pqs5hzxelntsxu5niqrq	33	43	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	33	44	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	33	45	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	33	46	thin	thin	JJ
work_nlc445pqs5hzxelntsxu5niqrq	33	47	corpus	corpus	NN
work_nlc445pqs5hzxelntsxu5niqrq	33	48	callosum	callosum	NN
work_nlc445pqs5hzxelntsxu5niqrq	33	49	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	33	50	as	as	RB
work_nlc445pqs5hzxelntsxu5niqrq	33	51	well	well	RB
work_nlc445pqs5hzxelntsxu5niqrq	33	52	as	as	IN
work_nlc445pqs5hzxelntsxu5niqrq	33	53	brainstem	brainstem	NN
work_nlc445pqs5hzxelntsxu5niqrq	33	54	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	33	55	cerebellar	cerebellar	JJ
work_nlc445pqs5hzxelntsxu5niqrq	33	56	atrophy	atrophy	NN
work_nlc445pqs5hzxelntsxu5niqrq	33	57	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	34	1	These	these	DT
work_nlc445pqs5hzxelntsxu5niqrq	34	2	findings	finding	NNS
work_nlc445pqs5hzxelntsxu5niqrq	34	3	persisted	persist	VBD
work_nlc445pqs5hzxelntsxu5niqrq	34	4	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	34	5	26	26	CD
work_nlc445pqs5hzxelntsxu5niqrq	34	6	months	month	NNS
work_nlc445pqs5hzxelntsxu5niqrq	34	7	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	34	8	further	further	JJ
work_nlc445pqs5hzxelntsxu5niqrq	34	9	cortical	cortical	JJ
work_nlc445pqs5hzxelntsxu5niqrq	34	10	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	34	11	brainstem	brainstem	NN
work_nlc445pqs5hzxelntsxu5niqrq	34	12	atrophy	atrophy	NN
work_nlc445pqs5hzxelntsxu5niqrq	34	13	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	35	1	There	there	EX
work_nlc445pqs5hzxelntsxu5niqrq	35	2	was	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	35	3	no	no	DT
work_nlc445pqs5hzxelntsxu5niqrq	35	4	enhancement	enhancement	NN
work_nlc445pqs5hzxelntsxu5niqrq	35	5	on	on	IN
work_nlc445pqs5hzxelntsxu5niqrq	35	6	gadolinium	gadolinium	NN
work_nlc445pqs5hzxelntsxu5niqrq	35	7	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	36	1	MR	MR	NNP
work_nlc445pqs5hzxelntsxu5niqrq	36	2	spec-	spec-	NN
work_nlc445pqs5hzxelntsxu5niqrq	36	3	troscopy	troscopy	NNP
work_nlc445pqs5hzxelntsxu5niqrq	36	4	demonstrated	demonstrate	VBD
work_nlc445pqs5hzxelntsxu5niqrq	36	5	lactate	lactate	JJ
work_nlc445pqs5hzxelntsxu5niqrq	36	6	peak	peak	NN
work_nlc445pqs5hzxelntsxu5niqrq	36	7	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	36	8	an	an	DT
work_nlc445pqs5hzxelntsxu5niqrq	36	9	increased	increase	VBN
work_nlc445pqs5hzxelntsxu5niqrq	36	10	choline-	choline-	NN
work_nlc445pqs5hzxelntsxu5niqrq	36	11	to	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	36	12	-	-	HYPH
work_nlc445pqs5hzxelntsxu5niqrq	36	13	NAA	NAA	NNP
work_nlc445pqs5hzxelntsxu5niqrq	36	14	ratio	ratio	NN
work_nlc445pqs5hzxelntsxu5niqrq	36	15	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	37	1	No	no	DT
work_nlc445pqs5hzxelntsxu5niqrq	37	2	vessel	vessel	NN
work_nlc445pqs5hzxelntsxu5niqrq	37	3	imaging	imaging	NNP
work_nlc445pqs5hzxelntsxu5niqrq	37	4	was	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	37	5	acquired	acquire	VBN
work_nlc445pqs5hzxelntsxu5niqrq	37	6	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	38	1	Chromosomal	chromosomal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	38	2	microarray	microarray	NN
work_nlc445pqs5hzxelntsxu5niqrq	38	3	done	do	VBN
work_nlc445pqs5hzxelntsxu5niqrq	38	4	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	38	5	age	age	NN
work_nlc445pqs5hzxelntsxu5niqrq	38	6	1	1	CD
work_nlc445pqs5hzxelntsxu5niqrq	38	7	year	year	NN
work_nlc445pqs5hzxelntsxu5niqrq	38	8	was	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	38	9	normal	normal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	38	10	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	39	1	Initial	initial	JJ
work_nlc445pqs5hzxelntsxu5niqrq	39	2	testing	testing	NN
work_nlc445pqs5hzxelntsxu5niqrq	39	3	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	39	4	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	39	5	encephalitis	encephalitis	NNP
work_nlc445pqs5hzxelntsxu5niqrq	39	6	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	39	7	TREX1	TREX1	NNP
work_nlc445pqs5hzxelntsxu5niqrq	39	8	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	39	9	followed	follow	VBN
work_nlc445pqs5hzxelntsxu5niqrq	39	10	by	by	IN
work_nlc445pqs5hzxelntsxu5niqrq	39	11	testing	test	VBG
work_nlc445pqs5hzxelntsxu5niqrq	39	12	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	39	13	RNASEH2A	RNASEH2A	NNP
work_nlc445pqs5hzxelntsxu5niqrq	39	14	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	39	15	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	39	16	leukoencephalopathy	leukoencephalopathy	NNP
work_nlc445pqs5hzxelntsxu5niqrq	39	17	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	39	18	eIF2B5	eIF2B5	NNP
work_nlc445pqs5hzxelntsxu5niqrq	39	19	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	39	20	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	39	21	leukodystro-	leukodystro-	JJ
work_nlc445pqs5hzxelntsxu5niqrq	39	22	phies	phie	NNS
work_nlc445pqs5hzxelntsxu5niqrq	39	23	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	39	24	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	39	25	fibroblasts	fibroblast	NNS
work_nlc445pqs5hzxelntsxu5niqrq	39	26	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	39	27	respiratory	respiratory	JJ
work_nlc445pqs5hzxelntsxu5niqrq	39	28	chain	chain	NN
work_nlc445pqs5hzxelntsxu5niqrq	39	29	analysis	analysis	NN
work_nlc445pqs5hzxelntsxu5niqrq	39	30	were	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	39	31	negative	negative	JJ
work_nlc445pqs5hzxelntsxu5niqrq	39	32	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	40	1	He	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	40	2	was	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	40	3	then	then	RB
work_nlc445pqs5hzxelntsxu5niqrq	40	4	tested	test	VBN
work_nlc445pqs5hzxelntsxu5niqrq	40	5	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	40	6	an	an	DT
work_nlc445pqs5hzxelntsxu5niqrq	40	7	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	40	8	panel	panel	NN
work_nlc445pqs5hzxelntsxu5niqrq	40	9	including	include	VBG
work_nlc445pqs5hzxelntsxu5niqrq	40	10	TREX1	TREX1	NNS
work_nlc445pqs5hzxelntsxu5niqrq	40	11	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	40	12	RNASEH2A	RNASEH2A	NNP
work_nlc445pqs5hzxelntsxu5niqrq	40	13	/	/	SYM
work_nlc445pqs5hzxelntsxu5niqrq	40	14	B	B	NNP
work_nlc445pqs5hzxelntsxu5niqrq	40	15	/	/	SYM
work_nlc445pqs5hzxelntsxu5niqrq	40	16	C	C	NNP
work_nlc445pqs5hzxelntsxu5niqrq	40	17	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	40	18	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	40	19	SAMHD1	samhd1	NN
work_nlc445pqs5hzxelntsxu5niqrq	40	20	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	40	21	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	40	22	was	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	40	23	found	find	VBN
work_nlc445pqs5hzxelntsxu5niqrq	40	24	to	to	TO
work_nlc445pqs5hzxelntsxu5niqrq	40	25	have	have	VB
work_nlc445pqs5hzxelntsxu5niqrq	40	26	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	40	27	homozygous	homozygous	JJ
work_nlc445pqs5hzxelntsxu5niqrq	40	28	sequence	sequence	NN
work_nlc445pqs5hzxelntsxu5niqrq	40	29	variant	variant	JJ
work_nlc445pqs5hzxelntsxu5niqrq	40	30	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	40	31	c1265	c1265	NN
work_nlc445pqs5hzxelntsxu5niqrq	40	32	T	T	NNP
work_nlc445pqs5hzxelntsxu5niqrq	40	33	>	>	.
work_nlc445pqs5hzxelntsxu5niqrq	40	34	A	a	NN
work_nlc445pqs5hzxelntsxu5niqrq	40	35	;	;	:
work_nlc445pqs5hzxelntsxu5niqrq	40	36	p	p	NN
work_nlc445pqs5hzxelntsxu5niqrq	40	37	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	40	38	Leu422Gln	Leu422Gln	NNP
work_nlc445pqs5hzxelntsxu5niqrq	40	39	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	40	40	SAMHD1	SAMHD1	NNP
work_nlc445pqs5hzxelntsxu5niqrq	40	41	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	40	42	which	which	WDT
work_nlc445pqs5hzxelntsxu5niqrq	40	43	has	have	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	40	44	not	not	RB
work_nlc445pqs5hzxelntsxu5niqrq	40	45	been	be	VBN
work_nlc445pqs5hzxelntsxu5niqrq	40	46	previously	previously	RB
work_nlc445pqs5hzxelntsxu5niqrq	40	47	reported	report	VBN
work_nlc445pqs5hzxelntsxu5niqrq	40	48	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	40	49	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	40	50	literature	literature	NN
work_nlc445pqs5hzxelntsxu5niqrq	40	51	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	41	1	Both	both	DT
work_nlc445pqs5hzxelntsxu5niqrq	41	2	parents	parent	NNS
work_nlc445pqs5hzxelntsxu5niqrq	41	3	are	be	VBP
work_nlc445pqs5hzxelntsxu5niqrq	41	4	carriers	carrier	NNS
work_nlc445pqs5hzxelntsxu5niqrq	41	5	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	41	6	this	this	DT
work_nlc445pqs5hzxelntsxu5niqrq	41	7	variant	variant	NN
work_nlc445pqs5hzxelntsxu5niqrq	41	8	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	42	1	In	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	42	2	-	-	HYPH
work_nlc445pqs5hzxelntsxu5niqrq	42	3	silico	silico	NN
work_nlc445pqs5hzxelntsxu5niqrq	42	4	analysis	analysis	NN
work_nlc445pqs5hzxelntsxu5niqrq	42	5	was	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	42	6	done	do	VBN
work_nlc445pqs5hzxelntsxu5niqrq	42	7	using	use	VBG
work_nlc445pqs5hzxelntsxu5niqrq	42	8	four	four	CD
work_nlc445pqs5hzxelntsxu5niqrq	42	9	different	different	JJ
work_nlc445pqs5hzxelntsxu5niqrq	42	10	programs	program	NNS
work_nlc445pqs5hzxelntsxu5niqrq	42	11	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	42	12	Align	align	VB
work_nlc445pqs5hzxelntsxu5niqrq	42	13	GVGD	GVGD	NNP
work_nlc445pqs5hzxelntsxu5niqrq	42	14	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	42	15	SIFT	SIFT	NNP
work_nlc445pqs5hzxelntsxu5niqrq	42	16	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	42	17	MutationTa-	MutationTa-	NNP
work_nlc445pqs5hzxelntsxu5niqrq	42	18	ster	ster	NNP
work_nlc445pqs5hzxelntsxu5niqrq	42	19	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	42	20	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	42	21	PolyPhen-2	PolyPhen-2	NNP
work_nlc445pqs5hzxelntsxu5niqrq	42	22	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	42	23	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	43	1	Based	base	VBN
work_nlc445pqs5hzxelntsxu5niqrq	43	2	on	on	IN
work_nlc445pqs5hzxelntsxu5niqrq	43	3	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	43	4	current	current	JJ
work_nlc445pqs5hzxelntsxu5niqrq	43	5	available	available	JJ
work_nlc445pqs5hzxelntsxu5niqrq	43	6	information	information	NN
work_nlc445pqs5hzxelntsxu5niqrq	43	7	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	43	8	SAMHD1	SAMHD1	''
work_nlc445pqs5hzxelntsxu5niqrq	43	9	:	:	:
work_nlc445pqs5hzxelntsxu5niqrq	43	10	c.1265	c.1265	NNP
work_nlc445pqs5hzxelntsxu5niqrq	43	11	T	T	NNP
work_nlc445pqs5hzxelntsxu5niqrq	43	12	>	>	NN
work_nlc445pqs5hzxelntsxu5niqrq	43	13	A	a	NN
work_nlc445pqs5hzxelntsxu5niqrq	43	14	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	43	15	classified	classify	VBN
work_nlc445pqs5hzxelntsxu5niqrq	43	16	as	as	IN
work_nlc445pqs5hzxelntsxu5niqrq	43	17	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	43	18	“	"	``
work_nlc445pqs5hzxelntsxu5niqrq	43	19	variant	variant	NN
work_nlc445pqs5hzxelntsxu5niqrq	43	20	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	43	21	uncertain	uncertain	JJ
work_nlc445pqs5hzxelntsxu5niqrq	43	22	significance	significance	NN
work_nlc445pqs5hzxelntsxu5niqrq	43	23	”	"	''
work_nlc445pqs5hzxelntsxu5niqrq	43	24	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	43	25	VUS	VUS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	43	26	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	43	27	ACMG	ACMG	NNP
work_nlc445pqs5hzxelntsxu5niqrq	43	28	3	3	CD
work_nlc445pqs5hzxelntsxu5niqrq	43	29	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	43	30	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	44	1	Evidence	evidence	NN
work_nlc445pqs5hzxelntsxu5niqrq	44	2	supporting	support	VBG
work_nlc445pqs5hzxelntsxu5niqrq	44	3	pathogenicity	pathogenicity	NN
work_nlc445pqs5hzxelntsxu5niqrq	44	4	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	44	5	PM2	PM2	NNP
work_nlc445pqs5hzxelntsxu5niqrq	44	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	44	7	PP3	PP3	NNP
work_nlc445pqs5hzxelntsxu5niqrq	44	8	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	44	9	PP4	PP4	NNP
work_nlc445pqs5hzxelntsxu5niqrq	44	10	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	44	11	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	44	12	falls	fall	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	44	13	short	short	RB
work_nlc445pqs5hzxelntsxu5niqrq	44	14	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	44	15	being	be	VBG
work_nlc445pqs5hzxelntsxu5niqrq	44	16	sufficient	sufficient	JJ
work_nlc445pqs5hzxelntsxu5niqrq	44	17	to	to	TO
work_nlc445pqs5hzxelntsxu5niqrq	44	18	classify	classify	VB
work_nlc445pqs5hzxelntsxu5niqrq	44	19	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	44	20	variant	variant	NN
work_nlc445pqs5hzxelntsxu5niqrq	44	21	as	as	IN
work_nlc445pqs5hzxelntsxu5niqrq	44	22	“	"	``
work_nlc445pqs5hzxelntsxu5niqrq	44	23	likely	likely	RB
work_nlc445pqs5hzxelntsxu5niqrq	44	24	pathogenic	pathogenic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	44	25	”	"	''
work_nlc445pqs5hzxelntsxu5niqrq	44	26	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	44	27	ACMG	ACMG	NNP
work_nlc445pqs5hzxelntsxu5niqrq	44	28	4	4	CD
work_nlc445pqs5hzxelntsxu5niqrq	44	29	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	44	30	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	45	1	A	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	45	2	different	different	JJ
work_nlc445pqs5hzxelntsxu5niqrq	45	3	amino	amino	NN
work_nlc445pqs5hzxelntsxu5niqrq	45	4	acid	acid	NN
work_nlc445pqs5hzxelntsxu5niqrq	45	5	substitution	substitution	NN
work_nlc445pqs5hzxelntsxu5niqrq	45	6	has	have	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	45	7	been	be	VBN
work_nlc445pqs5hzxelntsxu5niqrq	45	8	reported	report	VBN
work_nlc445pqs5hzxelntsxu5niqrq	45	9	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	45	10	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	45	11	same	same	JJ
work_nlc445pqs5hzxelntsxu5niqrq	45	12	position	position	NN
work_nlc445pqs5hzxelntsxu5niqrq	45	13	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	45	14	c.1265	c.1265	NNP
work_nlc445pqs5hzxelntsxu5niqrq	45	15	T	T	NNP
work_nlc445pqs5hzxelntsxu5niqrq	45	16	>	>	FW
work_nlc445pqs5hzxelntsxu5niqrq	45	17	C	c	NN
work_nlc445pqs5hzxelntsxu5niqrq	45	18	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	45	19	p	p	NNP
work_nlc445pqs5hzxelntsxu5niqrq	45	20	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	45	21	Leu422Pro	Leu422Pro	NNP
work_nlc445pqs5hzxelntsxu5niqrq	45	22	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	45	23	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	45	24	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	45	25	case	case	NN
work_nlc445pqs5hzxelntsxu5niqrq	45	26	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	45	27	gastric	gastric	JJ
work_nlc445pqs5hzxelntsxu5niqrq	45	28	adenocarcinoma	adenocarcinoma	NN
work_nlc445pqs5hzxelntsxu5niqrq	45	29	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	45	30	COSMIC	COSMIC	NNP
work_nlc445pqs5hzxelntsxu5niqrq	45	31	ID	ID	NNP
work_nlc445pqs5hzxelntsxu5niqrq	45	32	:	:	:
work_nlc445pqs5hzxelntsxu5niqrq	45	33	COSM4098095	cosm4098095	ADD
work_nlc445pqs5hzxelntsxu5niqrq	45	34	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	45	35	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	46	1	Based	base	VBN
work_nlc445pqs5hzxelntsxu5niqrq	46	2	on	on	IN
work_nlc445pqs5hzxelntsxu5niqrq	46	3	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	46	4	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	46	5	-	-	HYPH
work_nlc445pqs5hzxelntsxu5niqrq	46	6	silico	silico	NN
work_nlc445pqs5hzxelntsxu5niqrq	46	7	FATHMM	FATHMM	NNP
work_nlc445pqs5hzxelntsxu5niqrq	46	8	algorithm	algorithm	NN
work_nlc445pqs5hzxelntsxu5niqrq	46	9	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	46	10	this	this	DT
work_nlc445pqs5hzxelntsxu5niqrq	46	11	variant	variant	NN
work_nlc445pqs5hzxelntsxu5niqrq	46	12	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	46	13	classified	classify	VBN
work_nlc445pqs5hzxelntsxu5niqrq	46	14	as	as	IN
work_nlc445pqs5hzxelntsxu5niqrq	46	15	“	"	``
work_nlc445pqs5hzxelntsxu5niqrq	46	16	pathogenic	pathogenic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	46	17	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	46	18	”	"	''
work_nlc445pqs5hzxelntsxu5niqrq	46	19	This	this	DT
work_nlc445pqs5hzxelntsxu5niqrq	46	20	evidence	evidence	NN
work_nlc445pqs5hzxelntsxu5niqrq	46	21	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	46	22	PM5	PM5	NNP
work_nlc445pqs5hzxelntsxu5niqrq	46	23	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	46	24	was	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	46	25	not	not	RB
work_nlc445pqs5hzxelntsxu5niqrq	46	26	included	include	VBN
work_nlc445pqs5hzxelntsxu5niqrq	46	27	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	46	28	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	46	29	final	final	JJ
work_nlc445pqs5hzxelntsxu5niqrq	46	30	ACMG	ACMG	NNP
work_nlc445pqs5hzxelntsxu5niqrq	46	31	classification	classification	NN
work_nlc445pqs5hzxelntsxu5niqrq	46	32	because	because	IN
work_nlc445pqs5hzxelntsxu5niqrq	46	33	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	46	34	pathogeni-	pathogeni-	JJ
work_nlc445pqs5hzxelntsxu5niqrq	46	35	city	city	NN
work_nlc445pqs5hzxelntsxu5niqrq	46	36	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	46	37	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	46	38	c.1265	c.1265	NNP
work_nlc445pqs5hzxelntsxu5niqrq	46	39	T	T	NNP
work_nlc445pqs5hzxelntsxu5niqrq	46	40	>	>	FW
work_nlc445pqs5hzxelntsxu5niqrq	46	41	C	C	NNP
work_nlc445pqs5hzxelntsxu5niqrq	46	42	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	46	43	p	p	NN
work_nlc445pqs5hzxelntsxu5niqrq	46	44	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	46	45	Leu422Pro	leu422pro	LS
work_nlc445pqs5hzxelntsxu5niqrq	46	46	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	46	47	variant	variant	NNP
work_nlc445pqs5hzxelntsxu5niqrq	46	48	was	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	46	49	based	base	VBN
work_nlc445pqs5hzxelntsxu5niqrq	46	50	entirely	entirely	RB
work_nlc445pqs5hzxelntsxu5niqrq	46	51	on	on	IN
work_nlc445pqs5hzxelntsxu5niqrq	46	52	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	46	53	-	-	HYPH
work_nlc445pqs5hzxelntsxu5niqrq	46	54	silico	silico	NN
work_nlc445pqs5hzxelntsxu5niqrq	46	55	predictions	prediction	NNS
work_nlc445pqs5hzxelntsxu5niqrq	46	56	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	47	1	If	if	IN
work_nlc445pqs5hzxelntsxu5niqrq	47	2	this	this	DT
work_nlc445pqs5hzxelntsxu5niqrq	47	3	additional	additional	JJ
work_nlc445pqs5hzxelntsxu5niqrq	47	4	information	information	NN
work_nlc445pqs5hzxelntsxu5niqrq	47	5	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	47	6	considered	consider	VBN
work_nlc445pqs5hzxelntsxu5niqrq	47	7	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	47	8	PP5	PP5	NNP
work_nlc445pqs5hzxelntsxu5niqrq	47	9	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	47	10	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	47	11	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	47	12	SAMHD1	samhd1	NN
work_nlc445pqs5hzxelntsxu5niqrq	47	13	:	:	:
work_nlc445pqs5hzxelntsxu5niqrq	47	14	c.1265	c.1265	NNP
work_nlc445pqs5hzxelntsxu5niqrq	47	15	T	t	NN
work_nlc445pqs5hzxelntsxu5niqrq	47	16	>	>	.
work_nlc445pqs5hzxelntsxu5niqrq	47	17	A	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	47	18	variant	variant	NN
work_nlc445pqs5hzxelntsxu5niqrq	47	19	would	would	MD
work_nlc445pqs5hzxelntsxu5niqrq	47	20	be	be	VB
work_nlc445pqs5hzxelntsxu5niqrq	47	21	classified	classify	VBN
work_nlc445pqs5hzxelntsxu5niqrq	47	22	as	as	IN
work_nlc445pqs5hzxelntsxu5niqrq	47	23	“	"	``
work_nlc445pqs5hzxelntsxu5niqrq	47	24	likely	likely	RB
work_nlc445pqs5hzxelntsxu5niqrq	47	25	pathogenic	pathogenic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	47	26	”	"	''
work_nlc445pqs5hzxelntsxu5niqrq	47	27	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	47	28	ACMG	ACMG	NNP
work_nlc445pqs5hzxelntsxu5niqrq	47	29	4	4	CD
work_nlc445pqs5hzxelntsxu5niqrq	47	30	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	47	31	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	48	1	Homozygous	homozygous	JJ
work_nlc445pqs5hzxelntsxu5niqrq	48	2	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	48	3	compound	compound	JJ
work_nlc445pqs5hzxelntsxu5niqrq	48	4	heterozygous	heterozygous	JJ
work_nlc445pqs5hzxelntsxu5niqrq	48	5	mutations	mutation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	48	6	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	48	7	SAMHD1	samhd1	NN
work_nlc445pqs5hzxelntsxu5niqrq	48	8	were	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	48	9	first	first	RB
work_nlc445pqs5hzxelntsxu5niqrq	48	10	implicated	implicate	VBN
work_nlc445pqs5hzxelntsxu5niqrq	48	11	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	48	12	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	48	13	patients	patient	NNS
work_nlc445pqs5hzxelntsxu5niqrq	48	14	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	48	15	2009.3	2009.3	CD
work_nlc445pqs5hzxelntsxu5niqrq	48	16	Approximately	approximately	RB
work_nlc445pqs5hzxelntsxu5niqrq	48	17	13	13	CD
work_nlc445pqs5hzxelntsxu5niqrq	48	18	%	%	NN
work_nlc445pqs5hzxelntsxu5niqrq	48	19	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	48	20	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	48	21	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	48	22	caused	cause	VBN
work_nlc445pqs5hzxelntsxu5niqrq	48	23	by	by	IN
work_nlc445pqs5hzxelntsxu5niqrq	48	24	mutations	mutation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	48	25	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	48	26	SAMHD1	SAMHD1	NNP
work_nlc445pqs5hzxelntsxu5niqrq	48	27	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	48	28	including	include	VBG
work_nlc445pqs5hzxelntsxu5niqrq	48	29	missense	missense	NN
work_nlc445pqs5hzxelntsxu5niqrq	48	30	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	48	31	null	null	NN
work_nlc445pqs5hzxelntsxu5niqrq	48	32	mutations	mutation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	48	33	as	as	RB
work_nlc445pqs5hzxelntsxu5niqrq	48	34	well	well	RB
work_nlc445pqs5hzxelntsxu5niqrq	48	35	as	as	IN
work_nlc445pqs5hzxelntsxu5niqrq	48	36	large	large	JJ
work_nlc445pqs5hzxelntsxu5niqrq	48	37	deletions).3.4	deletions).3.4	NN
work_nlc445pqs5hzxelntsxu5niqrq	48	38	The	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	48	39	majority	majority	NN
work_nlc445pqs5hzxelntsxu5niqrq	48	40	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	48	41	these	these	DT
work_nlc445pqs5hzxelntsxu5niqrq	48	42	patients	patient	NNS
work_nlc445pqs5hzxelntsxu5niqrq	48	43	have	have	VBP
work_nlc445pqs5hzxelntsxu5niqrq	48	44	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	48	45	normal	normal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	48	46	neonatal	neonatal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	48	47	course	course	NN
work_nlc445pqs5hzxelntsxu5niqrq	48	48	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	48	49	neurological	neurological	JJ
work_nlc445pqs5hzxelntsxu5niqrq	48	50	symptoms	symptom	NNS
work_nlc445pqs5hzxelntsxu5niqrq	48	51	presenting	present	VBG
work_nlc445pqs5hzxelntsxu5niqrq	48	52	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	48	53	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	48	54	first	first	JJ
work_nlc445pqs5hzxelntsxu5niqrq	48	55	year	year	NN
work_nlc445pqs5hzxelntsxu5niqrq	48	56	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	48	57	life	life	NN
work_nlc445pqs5hzxelntsxu5niqrq	48	58	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	49	1	SAMHD1	SAMHD1	NNP
work_nlc445pqs5hzxelntsxu5niqrq	49	2	mutations	mutation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	49	3	have	have	VBP
work_nlc445pqs5hzxelntsxu5niqrq	49	4	been	be	VBN
work_nlc445pqs5hzxelntsxu5niqrq	49	5	found	find	VBN
work_nlc445pqs5hzxelntsxu5niqrq	49	6	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	49	7	Amish	Amish	NNP
work_nlc445pqs5hzxelntsxu5niqrq	49	8	populations,5	populations,5	NNP
work_nlc445pqs5hzxelntsxu5niqrq	49	9	Maltese	Maltese	NNP
work_nlc445pqs5hzxelntsxu5niqrq	49	10	patients,6	patients,6	NN
work_nlc445pqs5hzxelntsxu5niqrq	49	11	Ashkenazi	ashkenazi	NN
work_nlc445pqs5hzxelntsxu5niqrq	49	12	Jews,6	jews,6	NN
work_nlc445pqs5hzxelntsxu5niqrq	49	13	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	49	14	patients	patient	NNS
work_nlc445pqs5hzxelntsxu5niqrq	49	15	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	49	16	Northern	northern	JJ
work_nlc445pqs5hzxelntsxu5niqrq	49	17	European	European	NNP
work_nlc445pqs5hzxelntsxu5niqrq	49	18	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	49	19	North	North	NNP
work_nlc445pqs5hzxelntsxu5niqrq	49	20	American	American	NNP
work_nlc445pqs5hzxelntsxu5niqrq	49	21	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	49	22	Asian	asian	JJ
work_nlc445pqs5hzxelntsxu5niqrq	49	23	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	49	24	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	49	25	Australian	Australian	NNP
work_nlc445pqs5hzxelntsxu5niqrq	49	26	descent.4	descent.4	NNP
work_nlc445pqs5hzxelntsxu5niqrq	49	27	The	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	49	28	phenotypic	phenotypic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	49	29	similarities	similarity	NNS
work_nlc445pqs5hzxelntsxu5niqrq	49	30	between	between	IN
work_nlc445pqs5hzxelntsxu5niqrq	49	31	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	49	32	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	49	33	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	49	34	encepha-	encepha-	JJ
work_nlc445pqs5hzxelntsxu5niqrq	49	35	litis	litis	NN
work_nlc445pqs5hzxelntsxu5niqrq	49	36	are	be	VBP
work_nlc445pqs5hzxelntsxu5niqrq	49	37	well	well	RB
work_nlc445pqs5hzxelntsxu5niqrq	49	38	-	-	HYPH
work_nlc445pqs5hzxelntsxu5niqrq	49	39	described	describe	VBN
work_nlc445pqs5hzxelntsxu5niqrq	49	40	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	50	1	Currently	currently	RB
work_nlc445pqs5hzxelntsxu5niqrq	50	2	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	50	3	only	only	RB
work_nlc445pqs5hzxelntsxu5niqrq	50	4	TREX1	trex1	NN
work_nlc445pqs5hzxelntsxu5niqrq	50	5	mutations	mutation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	50	6	have	have	VBP
work_nlc445pqs5hzxelntsxu5niqrq	50	7	been	be	VBN
work_nlc445pqs5hzxelntsxu5niqrq	50	8	identified	identify	VBN
work_nlc445pqs5hzxelntsxu5niqrq	50	9	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	50	10	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	50	11	encephalitis.2	encephalitis.2	CD
work_nlc445pqs5hzxelntsxu5niqrq	50	12	To	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	50	13	our	-PRON-	PRP$
work_nlc445pqs5hzxelntsxu5niqrq	50	14	knowledge	knowledge	NN
work_nlc445pqs5hzxelntsxu5niqrq	50	15	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	50	16	there	there	EX
work_nlc445pqs5hzxelntsxu5niqrq	50	17	are	be	VBP
work_nlc445pqs5hzxelntsxu5niqrq	50	18	no	no	DT
work_nlc445pqs5hzxelntsxu5niqrq	50	19	reports	report	NNS
work_nlc445pqs5hzxelntsxu5niqrq	50	20	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	50	21	SAMHD1	samhd1	NN
work_nlc445pqs5hzxelntsxu5niqrq	50	22	mutations	mutation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	50	23	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	50	24	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	50	25	children	child	NNS
work_nlc445pqs5hzxelntsxu5niqrq	50	26	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	51	1	THE	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	51	2	CANADIAN	canadian	JJ
work_nlc445pqs5hzxelntsxu5niqrq	51	3	JOURNAL	JOURNAL	NNS
work_nlc445pqs5hzxelntsxu5niqrq	51	4	OF	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	51	5	NEUROLOGICAL	NEUROLOGICAL	NNP
work_nlc445pqs5hzxelntsxu5niqrq	51	6	SCIENCES	SCIENCES	NNP
work_nlc445pqs5hzxelntsxu5niqrq	51	7	749	749	CD
work_nlc445pqs5hzxelntsxu5niqrq	51	8	https://www.cambridge.org/core/terms	https://www.cambridge.org/core/term	NNS
work_nlc445pqs5hzxelntsxu5niqrq	51	9	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	52	1	https://doi.org/10.1017/cjn.2017.226	https://doi.org/10.1017/cjn.2017.226	NNP
work_nlc445pqs5hzxelntsxu5niqrq	52	2	Downloaded	download	VBN
work_nlc445pqs5hzxelntsxu5niqrq	52	3	from	from	IN
work_nlc445pqs5hzxelntsxu5niqrq	52	4	https://www.cambridge.org/core	https://www.cambridge.org/core	ADD
work_nlc445pqs5hzxelntsxu5niqrq	52	5	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	53	1	Carnegie	Carnegie	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	2	Mellon	Mellon	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	3	University	University	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	4	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	53	5	on	on	IN
work_nlc445pqs5hzxelntsxu5niqrq	53	6	06	06	CD
work_nlc445pqs5hzxelntsxu5niqrq	53	7	Apr	Apr	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	8	2021	2021	CD
work_nlc445pqs5hzxelntsxu5niqrq	53	9	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	53	10	01:38:33	01:38:33	CD
work_nlc445pqs5hzxelntsxu5niqrq	53	11	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	53	12	subject	subject	JJ
work_nlc445pqs5hzxelntsxu5niqrq	53	13	to	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	53	14	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	53	15	Cambridge	Cambridge	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	16	Core	Core	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	17	terms	term	NNS
work_nlc445pqs5hzxelntsxu5niqrq	53	18	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	53	19	use	use	NN
work_nlc445pqs5hzxelntsxu5niqrq	53	20	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	53	21	available	available	JJ
work_nlc445pqs5hzxelntsxu5niqrq	53	22	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	53	23	https://www.cambridge.org/core/terms	https://www.cambridge.org/core/terms	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	24	https://doi.org/10.1017/cjn.2017.226	https://doi.org/10.1017/cjn.2017.226	PRP
work_nlc445pqs5hzxelntsxu5niqrq	53	25	https://www.cambridge.org/core	https://www.cambridge.org/core	CD
work_nlc445pqs5hzxelntsxu5niqrq	53	26	Several	several	JJ
work_nlc445pqs5hzxelntsxu5niqrq	53	27	conditions	condition	NNS
work_nlc445pqs5hzxelntsxu5niqrq	53	28	are	be	VBP
work_nlc445pqs5hzxelntsxu5niqrq	53	29	associated	associate	VBN
work_nlc445pqs5hzxelntsxu5niqrq	53	30	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	53	31	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	32	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	53	33	including	include	VBG
work_nlc445pqs5hzxelntsxu5niqrq	53	34	glau-	glau-	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	35	coma	coma	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	36	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	53	37	autoimmune	autoimmune	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	38	diseases	disease	NNS
work_nlc445pqs5hzxelntsxu5niqrq	53	39	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	53	40	familial	familial	NN
work_nlc445pqs5hzxelntsxu5niqrq	53	41	chilblain	chilblain	NN
work_nlc445pqs5hzxelntsxu5niqrq	53	42	cardiomyopathy	cardiomyopathy	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	43	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	53	44	intracerebral	intracerebral	JJ
work_nlc445pqs5hzxelntsxu5niqrq	53	45	vasculitis,7	vasculitis,7	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	46	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	53	47	arthropathy.4	arthropathy.4	LS
work_nlc445pqs5hzxelntsxu5niqrq	53	48	Among	among	IN
work_nlc445pqs5hzxelntsxu5niqrq	53	49	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	50	patients	patient	NNS
work_nlc445pqs5hzxelntsxu5niqrq	53	51	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	53	52	those	those	DT
work_nlc445pqs5hzxelntsxu5niqrq	53	53	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	53	54	SAMHD1	samhd1	NN
work_nlc445pqs5hzxelntsxu5niqrq	53	55	mutations	mutation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	53	56	have	have	VBP
work_nlc445pqs5hzxelntsxu5niqrq	53	57	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	53	58	higher	high	JJR
work_nlc445pqs5hzxelntsxu5niqrq	53	59	likelihood	likelihood	NN
work_nlc445pqs5hzxelntsxu5niqrq	53	60	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	53	61	devel-	devel-	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	62	oping	oping	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	63	glaucoma	glaucoma	NNP
work_nlc445pqs5hzxelntsxu5niqrq	53	64	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	53	65	chilblains	chilblain	NNS
work_nlc445pqs5hzxelntsxu5niqrq	53	66	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	54	1	They	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	54	2	are	be	VBP
work_nlc445pqs5hzxelntsxu5niqrq	54	3	also	also	RB
work_nlc445pqs5hzxelntsxu5niqrq	54	4	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	54	5	only	only	JJ
work_nlc445pqs5hzxelntsxu5niqrq	54	6	group	group	NN
work_nlc445pqs5hzxelntsxu5niqrq	54	7	to	to	TO
work_nlc445pqs5hzxelntsxu5niqrq	54	8	develop	develop	VB
work_nlc445pqs5hzxelntsxu5niqrq	54	9	intracerbral	intracerbral	JJ
work_nlc445pqs5hzxelntsxu5niqrq	54	10	vasculopathy	vasculopathy	NNP
work_nlc445pqs5hzxelntsxu5niqrq	54	11	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	54	12	arthropathy	arthropathy	JJ
work_nlc445pqs5hzxelntsxu5niqrq	54	13	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	55	1	In	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	55	2	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	55	3	series	series	NN
work_nlc445pqs5hzxelntsxu5niqrq	55	4	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	55	5	five	five	CD
work_nlc445pqs5hzxelntsxu5niqrq	55	6	patients	patient	NNS
work_nlc445pqs5hzxelntsxu5niqrq	55	7	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	55	8	SAMHD1	samhd1	NN
work_nlc445pqs5hzxelntsxu5niqrq	55	9	mutations	mutation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	55	10	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	55	11	all	all	DT
work_nlc445pqs5hzxelntsxu5niqrq	55	12	had	have	VBD
work_nlc445pqs5hzxelntsxu5niqrq	55	13	both	both	DT
work_nlc445pqs5hzxelntsxu5niqrq	55	14	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	55	15	cerebral	cerebral	JJ
work_nlc445pqs5hzxelntsxu5niqrq	55	16	arteriopathy	arteriopathy	JJ
work_nlc445pqs5hzxelntsxu5niqrq	55	17	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	55	18	peripheral	peripheral	JJ
work_nlc445pqs5hzxelntsxu5niqrq	55	19	vasculopathy	vasculopathy	NN
work_nlc445pqs5hzxelntsxu5niqrq	55	20	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	55	21	chilblains	chilblain	NNS
work_nlc445pqs5hzxelntsxu5niqrq	55	22	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	55	23	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	55	24	two	two	CD
work_nlc445pqs5hzxelntsxu5niqrq	55	25	had	have	VBD
work_nlc445pqs5hzxelntsxu5niqrq	55	26	leukocytoclastic	leukocytoclastic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	55	27	vasculitis	vasculitis	NN
work_nlc445pqs5hzxelntsxu5niqrq	55	28	on	on	IN
work_nlc445pqs5hzxelntsxu5niqrq	55	29	skin	skin	NN
work_nlc445pqs5hzxelntsxu5niqrq	55	30	biopsy.7	biopsy.7	PDT
work_nlc445pqs5hzxelntsxu5niqrq	55	31	These	these	DT
work_nlc445pqs5hzxelntsxu5niqrq	55	32	findings	finding	NNS
work_nlc445pqs5hzxelntsxu5niqrq	55	33	were	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	55	34	convincing	convince	VBG
work_nlc445pqs5hzxelntsxu5niqrq	55	35	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	55	36	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	55	37	role	role	NN
work_nlc445pqs5hzxelntsxu5niqrq	55	38	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	55	39	SAMHD1	samhd1	NN
work_nlc445pqs5hzxelntsxu5niqrq	55	40	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	55	41	systemic	systemic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	55	42	inflammation	inflammation	NN
work_nlc445pqs5hzxelntsxu5niqrq	55	43	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	56	1	Therefore	therefore	RB
work_nlc445pqs5hzxelntsxu5niqrq	56	2	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	56	3	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	56	4	this	this	DT
work_nlc445pqs5hzxelntsxu5niqrq	56	5	subgroup	subgroup	NN
work_nlc445pqs5hzxelntsxu5niqrq	56	6	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	56	7	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	56	8	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	56	9	anti	anti	JJ
work_nlc445pqs5hzxelntsxu5niqrq	56	10	-	-	JJ
work_nlc445pqs5hzxelntsxu5niqrq	56	11	inflammatory	inflammatory	JJ
work_nlc445pqs5hzxelntsxu5niqrq	56	12	therapies	therapy	NNS
work_nlc445pqs5hzxelntsxu5niqrq	56	13	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	56	14	immunosuppression	immunosuppression	NN
work_nlc445pqs5hzxelntsxu5niqrq	56	15	may	may	MD
work_nlc445pqs5hzxelntsxu5niqrq	56	16	help	help	VB
work_nlc445pqs5hzxelntsxu5niqrq	56	17	prevent	prevent	VB
work_nlc445pqs5hzxelntsxu5niqrq	56	18	disease	disease	NNP
work_nlc445pqs5hzxelntsxu5niqrq	56	19	progression	progression	NN
work_nlc445pqs5hzxelntsxu5niqrq	56	20	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	57	1	Patients	patient	NNS
work_nlc445pqs5hzxelntsxu5niqrq	57	2	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	57	3	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	57	4	display	display	NN
work_nlc445pqs5hzxelntsxu5niqrq	57	5	increased	increase	VBN
work_nlc445pqs5hzxelntsxu5niqrq	57	6	interferon	interferon	NN
work_nlc445pqs5hzxelntsxu5niqrq	57	7	activity	activity	NN
work_nlc445pqs5hzxelntsxu5niqrq	57	8	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	57	9	cerebrospinal	cerebrospinal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	57	10	fluid	fluid	NN
work_nlc445pqs5hzxelntsxu5niqrq	57	11	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	57	12	serum.8	serum.8	NNP
work_nlc445pqs5hzxelntsxu5niqrq	57	13	This	this	DT
work_nlc445pqs5hzxelntsxu5niqrq	57	14	was	be	VBD
work_nlc445pqs5hzxelntsxu5niqrq	57	15	not	not	RB
work_nlc445pqs5hzxelntsxu5niqrq	57	16	investigated	investigate	VBN
work_nlc445pqs5hzxelntsxu5niqrq	57	17	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	57	18	our	-PRON-	PRP$
work_nlc445pqs5hzxelntsxu5niqrq	57	19	patient	patient	NN
work_nlc445pqs5hzxelntsxu5niqrq	57	20	due	due	IN
work_nlc445pqs5hzxelntsxu5niqrq	57	21	to	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	57	22	his	-PRON-	PRP$
work_nlc445pqs5hzxelntsxu5niqrq	57	23	deteriorating	deteriorate	VBG
work_nlc445pqs5hzxelntsxu5niqrq	57	24	condition	condition	NN
work_nlc445pqs5hzxelntsxu5niqrq	57	25	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	58	1	Currently	currently	RB
work_nlc445pqs5hzxelntsxu5niqrq	58	2	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	58	3	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	58	4	Canada	Canada	NNP
work_nlc445pqs5hzxelntsxu5niqrq	58	5	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	58	6	TREX1	TREX1	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	58	7	testing	testing	NN
work_nlc445pqs5hzxelntsxu5niqrq	58	8	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	58	9	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	58	10	common	common	JJ
work_nlc445pqs5hzxelntsxu5niqrq	58	11	mutation	mutation	NN
work_nlc445pqs5hzxelntsxu5niqrq	58	12	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	58	13	typically	typically	RB
work_nlc445pqs5hzxelntsxu5niqrq	58	14	done	do	VBN
work_nlc445pqs5hzxelntsxu5niqrq	58	15	first	first	JJ
work_nlc445pqs5hzxelntsxu5niqrq	58	16	-	-	HYPH
work_nlc445pqs5hzxelntsxu5niqrq	58	17	line	line	NN
work_nlc445pqs5hzxelntsxu5niqrq	58	18	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	58	19	patients	patient	NNS
work_nlc445pqs5hzxelntsxu5niqrq	58	20	suspected	suspect	VBN
work_nlc445pqs5hzxelntsxu5niqrq	58	21	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	58	22	having	have	VBG
work_nlc445pqs5hzxelntsxu5niqrq	58	23	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	58	24	encephalitis	encephalitis	RB
work_nlc445pqs5hzxelntsxu5niqrq	58	25	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	59	1	If	if	IN
work_nlc445pqs5hzxelntsxu5niqrq	59	2	negative	negative	JJ
work_nlc445pqs5hzxelntsxu5niqrq	59	3	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	59	4	an	an	DT
work_nlc445pqs5hzxelntsxu5niqrq	59	5	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	59	6	panel	panel	NN
work_nlc445pqs5hzxelntsxu5niqrq	59	7	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	59	8	including	include	VBG
work_nlc445pqs5hzxelntsxu5niqrq	59	9	SAMHD1	samhd1	NN
work_nlc445pqs5hzxelntsxu5niqrq	59	10	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	59	11	or	or	CC
work_nlc445pqs5hzxelntsxu5niqrq	59	12	individual	individual	JJ
work_nlc445pqs5hzxelntsxu5niqrq	59	13	SAMHD1	SAMHD1	NNP
work_nlc445pqs5hzxelntsxu5niqrq	59	14	testing	testing	NN
work_nlc445pqs5hzxelntsxu5niqrq	59	15	should	should	MD
work_nlc445pqs5hzxelntsxu5niqrq	59	16	be	be	VB
work_nlc445pqs5hzxelntsxu5niqrq	59	17	performed	perform	VBN
work_nlc445pqs5hzxelntsxu5niqrq	59	18	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	60	1	A	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	60	2	wider	wide	JJR
work_nlc445pqs5hzxelntsxu5niqrq	60	3	genetic	genetic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	60	4	screen	screen	NN
work_nlc445pqs5hzxelntsxu5niqrq	60	5	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	60	6	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	60	7	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	60	8	population	population	NN
work_nlc445pqs5hzxelntsxu5niqrq	60	9	may	may	MD
work_nlc445pqs5hzxelntsxu5niqrq	60	10	help	help	VB
work_nlc445pqs5hzxelntsxu5niqrq	60	11	elucidate	elucidate	VB
work_nlc445pqs5hzxelntsxu5niqrq	60	12	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	60	13	carrier	carrier	NN
work_nlc445pqs5hzxelntsxu5niqrq	60	14	rate	rate	NN
work_nlc445pqs5hzxelntsxu5niqrq	60	15	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	60	16	SAMHD1	samhd1	NN
work_nlc445pqs5hzxelntsxu5niqrq	60	17	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	60	18	this	this	DT
work_nlc445pqs5hzxelntsxu5niqrq	60	19	population	population	NN
work_nlc445pqs5hzxelntsxu5niqrq	60	20	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	61	1	If	if	IN
work_nlc445pqs5hzxelntsxu5niqrq	61	2	additional	additional	JJ
work_nlc445pqs5hzxelntsxu5niqrq	61	3	cases	case	NNS
work_nlc445pqs5hzxelntsxu5niqrq	61	4	are	be	VBP
work_nlc445pqs5hzxelntsxu5niqrq	61	5	identified	identify	VBN
work_nlc445pqs5hzxelntsxu5niqrq	61	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	61	7	it	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	61	8	would	would	MD
work_nlc445pqs5hzxelntsxu5niqrq	61	9	assist	assist	VB
work_nlc445pqs5hzxelntsxu5niqrq	61	10	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	61	11	defining	define	VBG
work_nlc445pqs5hzxelntsxu5niqrq	61	12	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	61	13	pathogenicity	pathogenicity	NN
work_nlc445pqs5hzxelntsxu5niqrq	61	14	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	61	15	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	61	16	variant	variant	NN
work_nlc445pqs5hzxelntsxu5niqrq	61	17	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	62	1	This	this	DT
work_nlc445pqs5hzxelntsxu5niqrq	62	2	testing	testing	NN
work_nlc445pqs5hzxelntsxu5niqrq	62	3	would	would	MD
work_nlc445pqs5hzxelntsxu5niqrq	62	4	be	be	VB
work_nlc445pqs5hzxelntsxu5niqrq	62	5	particularly	particularly	RB
work_nlc445pqs5hzxelntsxu5niqrq	62	6	important	important	JJ
work_nlc445pqs5hzxelntsxu5niqrq	62	7	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	62	8	as	as	IN
work_nlc445pqs5hzxelntsxu5niqrq	62	9	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	62	10	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	62	11	SAMHD1	samhd1	NN
work_nlc445pqs5hzxelntsxu5niqrq	62	12	mutations	mutation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	62	13	can	can	MD
work_nlc445pqs5hzxelntsxu5niqrq	62	14	have	have	VB
work_nlc445pqs5hzxelntsxu5niqrq	62	15	potential	potential	JJ
work_nlc445pqs5hzxelntsxu5niqrq	62	16	complications	complication	NNS
work_nlc445pqs5hzxelntsxu5niqrq	62	17	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	62	18	including	include	VBG
work_nlc445pqs5hzxelntsxu5niqrq	62	19	glaucoma	glaucoma	NN
work_nlc445pqs5hzxelntsxu5niqrq	62	20	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	62	21	arteriopathy	arteriopathy	NN
work_nlc445pqs5hzxelntsxu5niqrq	62	22	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	62	23	requiring	require	VBG
work_nlc445pqs5hzxelntsxu5niqrq	62	24	anticipatory	anticipatory	JJ
work_nlc445pqs5hzxelntsxu5niqrq	62	25	screening	screening	NN
work_nlc445pqs5hzxelntsxu5niqrq	62	26	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	62	27	treatment	treatment	NN
work_nlc445pqs5hzxelntsxu5niqrq	62	28	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	63	1	Fur-	Fur-	NFP
work_nlc445pqs5hzxelntsxu5niqrq	63	2	thermore	thermore	NN
work_nlc445pqs5hzxelntsxu5niqrq	63	3	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	63	4	immunosuppressive	immunosuppressive	JJ
work_nlc445pqs5hzxelntsxu5niqrq	63	5	therapies	therapy	NNS
work_nlc445pqs5hzxelntsxu5niqrq	63	6	may	may	MD
work_nlc445pqs5hzxelntsxu5niqrq	63	7	play	play	VB
work_nlc445pqs5hzxelntsxu5niqrq	63	8	a	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	63	9	role	role	NN
work_nlc445pqs5hzxelntsxu5niqrq	63	10	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	63	11	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	63	12	management	management	NN
work_nlc445pqs5hzxelntsxu5niqrq	63	13	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	63	14	this	this	DT
work_nlc445pqs5hzxelntsxu5niqrq	63	15	subgroup	subgroup	NN
work_nlc445pqs5hzxelntsxu5niqrq	63	16	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	63	17	AGS	AGS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	63	18	patients	patient	NNS
work_nlc445pqs5hzxelntsxu5niqrq	63	19	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	64	1	ACKNOWLEDGMENTS	acknowledgment	NNS
work_nlc445pqs5hzxelntsxu5niqrq	64	2	We	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	64	3	thank	thank	VBP
work_nlc445pqs5hzxelntsxu5niqrq	64	4	Dr.	Dr.	NNP
work_nlc445pqs5hzxelntsxu5niqrq	64	5	John	John	NNP
work_nlc445pqs5hzxelntsxu5niqrq	64	6	Waye	Waye	NNP
work_nlc445pqs5hzxelntsxu5niqrq	64	7	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	64	8	his	-PRON-	PRP$
work_nlc445pqs5hzxelntsxu5niqrq	64	9	support	support	NN
work_nlc445pqs5hzxelntsxu5niqrq	64	10	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	64	11	writing	write	VBG
work_nlc445pqs5hzxelntsxu5niqrq	64	12	this	this	DT
work_nlc445pqs5hzxelntsxu5niqrq	64	13	manuscript	manuscript	NN
work_nlc445pqs5hzxelntsxu5niqrq	64	14	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	64	15	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	64	16	patient	patient	NN
work_nlc445pqs5hzxelntsxu5niqrq	64	17	’s	’s	POS
work_nlc445pqs5hzxelntsxu5niqrq	64	18	family	family	NN
work_nlc445pqs5hzxelntsxu5niqrq	64	19	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	64	20	their	-PRON-	PRP$
work_nlc445pqs5hzxelntsxu5niqrq	64	21	permission	permission	NN
work_nlc445pqs5hzxelntsxu5niqrq	64	22	to	to	TO
work_nlc445pqs5hzxelntsxu5niqrq	64	23	report	report	VB
work_nlc445pqs5hzxelntsxu5niqrq	64	24	his	-PRON-	PRP$
work_nlc445pqs5hzxelntsxu5niqrq	64	25	case	case	NN
work_nlc445pqs5hzxelntsxu5niqrq	64	26	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	65	1	DISCLOSURES	DISCLOSURES	NNP
work_nlc445pqs5hzxelntsxu5niqrq	65	2	Ashraf	Ashraf	NNP
work_nlc445pqs5hzxelntsxu5niqrq	65	3	Kharrat	Kharrat	NNP
work_nlc445pqs5hzxelntsxu5niqrq	65	4	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	65	5	Jennifer	Jennifer	NNP
work_nlc445pqs5hzxelntsxu5niqrq	65	6	MacKenzie	MacKenzie	NNP
work_nlc445pqs5hzxelntsxu5niqrq	65	7	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	65	8	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	65	9	Sunita	Sunita	NNP
work_nlc445pqs5hzxelntsxu5niqrq	65	10	Venkateswaran	Venkateswaran	NNP
work_nlc445pqs5hzxelntsxu5niqrq	65	11	do	do	VBP
work_nlc445pqs5hzxelntsxu5niqrq	65	12	not	not	RB
work_nlc445pqs5hzxelntsxu5niqrq	65	13	have	have	VB
work_nlc445pqs5hzxelntsxu5niqrq	65	14	anything	anything	NN
work_nlc445pqs5hzxelntsxu5niqrq	65	15	to	to	TO
work_nlc445pqs5hzxelntsxu5niqrq	65	16	disclose	disclose	VB
work_nlc445pqs5hzxelntsxu5niqrq	65	17	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	66	1	Ashraf	Ashraf	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	2	Kharrat	Kharrat	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	3	Department	Department	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	4	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	66	5	Paediatrics	Paediatrics	NNPS
work_nlc445pqs5hzxelntsxu5niqrq	66	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	66	7	University	University	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	8	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	66	9	Toronto	Toronto	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	10	Toronto	Toronto	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	11	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	66	12	Ontario	Ontario	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	13	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	66	14	Canada	Canada	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	15	Figure	Figure	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	16	1	1	CD
work_nlc445pqs5hzxelntsxu5niqrq	66	17	:	:	:
work_nlc445pqs5hzxelntsxu5niqrq	66	18	A	a	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	19	through	through	IN
work_nlc445pqs5hzxelntsxu5niqrq	66	20	C	c	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	21	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	66	22	age	age	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	23	4	4	CD
work_nlc445pqs5hzxelntsxu5niqrq	66	24	months	month	NNS
work_nlc445pqs5hzxelntsxu5niqrq	66	25	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	66	26	T2W	t2w	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	27	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	66	28	T2	T2	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	29	FLAIR	FLAIR	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	30	axial	axial	JJ
work_nlc445pqs5hzxelntsxu5niqrq	66	31	images	image	NNS
work_nlc445pqs5hzxelntsxu5niqrq	66	32	demonstrating	demonstrate	VBG
work_nlc445pqs5hzxelntsxu5niqrq	66	33	temporal	temporal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	66	34	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	66	35	frontal	frontal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	66	36	cysts	cyst	NNS
work_nlc445pqs5hzxelntsxu5niqrq	66	37	;	;	:
work_nlc445pqs5hzxelntsxu5niqrq	66	38	D	d	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	39	through	through	IN
work_nlc445pqs5hzxelntsxu5niqrq	66	40	F	F	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	41	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	66	42	age	age	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	43	11	11	CD
work_nlc445pqs5hzxelntsxu5niqrq	66	44	months	month	NNS
work_nlc445pqs5hzxelntsxu5niqrq	66	45	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	66	46	T2W	t2w	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	47	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	66	48	T2	T2	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	49	FLAIR	FLAIR	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	50	axial	axial	JJ
work_nlc445pqs5hzxelntsxu5niqrq	66	51	images	image	NNS
work_nlc445pqs5hzxelntsxu5niqrq	66	52	demonstrating	demonstrate	VBG
work_nlc445pqs5hzxelntsxu5niqrq	66	53	temporal	temporal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	66	54	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	66	55	frontal	frontal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	66	56	cysts	cyst	NNS
work_nlc445pqs5hzxelntsxu5niqrq	66	57	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	66	58	abnormal	abnormal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	66	59	myelination	myelination	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	60	status	status	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	61	;	;	:
work_nlc445pqs5hzxelntsxu5niqrq	66	62	G	g	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	63	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	66	64	age	age	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	65	18	18	CD
work_nlc445pqs5hzxelntsxu5niqrq	66	66	months	month	NNS
work_nlc445pqs5hzxelntsxu5niqrq	66	67	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	66	68	T1W	t1w	DT
work_nlc445pqs5hzxelntsxu5niqrq	66	69	axial	axial	JJ
work_nlc445pqs5hzxelntsxu5niqrq	66	70	image	image	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	71	demonstrating	demonstrate	VBG
work_nlc445pqs5hzxelntsxu5niqrq	66	72	left	left	JJ
work_nlc445pqs5hzxelntsxu5niqrq	66	73	glaucoma	glaucoma	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	74	;	;	:
work_nlc445pqs5hzxelntsxu5niqrq	66	75	H	h	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	76	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	66	77	age	age	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	78	18	18	CD
work_nlc445pqs5hzxelntsxu5niqrq	66	79	months	month	NNS
work_nlc445pqs5hzxelntsxu5niqrq	66	80	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	66	81	T2W	t2w	CD
work_nlc445pqs5hzxelntsxu5niqrq	66	82	axial	axial	JJ
work_nlc445pqs5hzxelntsxu5niqrq	66	83	image	image	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	84	demonstrating	demonstrate	VBG
work_nlc445pqs5hzxelntsxu5niqrq	66	85	ongoing	ongoing	JJ
work_nlc445pqs5hzxelntsxu5niqrq	66	86	cerebral	cerebral	JJ
work_nlc445pqs5hzxelntsxu5niqrq	66	87	atrophy	atrophy	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	88	;	;	:
work_nlc445pqs5hzxelntsxu5niqrq	66	89	I	-PRON-	PRP
work_nlc445pqs5hzxelntsxu5niqrq	66	90	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	66	91	age	age	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	92	18	18	CD
work_nlc445pqs5hzxelntsxu5niqrq	66	93	months	month	NNS
work_nlc445pqs5hzxelntsxu5niqrq	66	94	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	66	95	T1W	t1w	DT
work_nlc445pqs5hzxelntsxu5niqrq	66	96	axial	axial	JJ
work_nlc445pqs5hzxelntsxu5niqrq	66	97	image	image	NN
work_nlc445pqs5hzxelntsxu5niqrq	66	98	demonstrating	demonstrate	VBG
work_nlc445pqs5hzxelntsxu5niqrq	66	99	basal	basal	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	100	ganglia	ganglia	NNP
work_nlc445pqs5hzxelntsxu5niqrq	66	101	calcifications	calcification	NNS
work_nlc445pqs5hzxelntsxu5niqrq	66	102	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	67	1	THE	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	67	2	CANADIAN	canadian	JJ
work_nlc445pqs5hzxelntsxu5niqrq	67	3	JOURNAL	JOURNAL	NNS
work_nlc445pqs5hzxelntsxu5niqrq	67	4	OF	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	67	5	NEUROLOGICAL	NEUROLOGICAL	NNP
work_nlc445pqs5hzxelntsxu5niqrq	67	6	SCIENCES	SCIENCES	NNP
work_nlc445pqs5hzxelntsxu5niqrq	67	7	750	750	CD
work_nlc445pqs5hzxelntsxu5niqrq	67	8	https://www.cambridge.org/core/terms	https://www.cambridge.org/core/term	NNS
work_nlc445pqs5hzxelntsxu5niqrq	67	9	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	68	1	https://doi.org/10.1017/cjn.2017.226	https://doi.org/10.1017/cjn.2017.226	NNP
work_nlc445pqs5hzxelntsxu5niqrq	68	2	Downloaded	download	VBN
work_nlc445pqs5hzxelntsxu5niqrq	68	3	from	from	IN
work_nlc445pqs5hzxelntsxu5niqrq	68	4	https://www.cambridge.org/core	https://www.cambridge.org/core	ADD
work_nlc445pqs5hzxelntsxu5niqrq	68	5	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	69	1	Carnegie	Carnegie	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	2	Mellon	Mellon	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	3	University	University	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	4	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	69	5	on	on	IN
work_nlc445pqs5hzxelntsxu5niqrq	69	6	06	06	CD
work_nlc445pqs5hzxelntsxu5niqrq	69	7	Apr	Apr	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	8	2021	2021	CD
work_nlc445pqs5hzxelntsxu5niqrq	69	9	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	69	10	01:38:33	01:38:33	CD
work_nlc445pqs5hzxelntsxu5niqrq	69	11	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	69	12	subject	subject	JJ
work_nlc445pqs5hzxelntsxu5niqrq	69	13	to	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	69	14	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	69	15	Cambridge	Cambridge	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	16	Core	Core	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	17	terms	term	NNS
work_nlc445pqs5hzxelntsxu5niqrq	69	18	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	69	19	use	use	NN
work_nlc445pqs5hzxelntsxu5niqrq	69	20	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	69	21	available	available	JJ
work_nlc445pqs5hzxelntsxu5niqrq	69	22	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	69	23	https://www.cambridge.org/core/terms	https://www.cambridge.org/core/terms	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	24	https://doi.org/10.1017/cjn.2017.226	https://doi.org/10.1017/cjn.2017.226	PRP
work_nlc445pqs5hzxelntsxu5niqrq	69	25	https://www.cambridge.org/core	https://www.cambridge.org/core	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	69	26	Jennifer	Jennifer	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	27	MacKenzie	MacKenzie	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	28	Department	Department	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	29	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	69	30	Paediatrics	Paediatrics	NNPS
work_nlc445pqs5hzxelntsxu5niqrq	69	31	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	69	32	McMaster	McMaster	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	33	University	University	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	34	Hamilton	Hamilton	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	35	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	69	36	Ontario	Ontario	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	37	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	69	38	Canada	Canada	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	39	Sunita	Sunita	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	40	Venkateswaran	Venkateswaran	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	41	Division	Division	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	42	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	69	43	Paediatric	Paediatric	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	44	Neurology	Neurology	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	45	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	69	46	Department	Department	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	47	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	69	48	Paediatrics	Paediatrics	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	49	University	University	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	50	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	69	51	Ottawa	Ottawa	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	52	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	69	53	Ottawa	Ottawa	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	54	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	69	55	Ontario	Ontario	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	56	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	69	57	Canada	Canada	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	58	REFERENCES	REFERENCES	NNP
work_nlc445pqs5hzxelntsxu5niqrq	69	59	1	1	CD
work_nlc445pqs5hzxelntsxu5niqrq	69	60	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	70	1	Black	black	JJ
work_nlc445pqs5hzxelntsxu5niqrq	70	2	DN	DN	NNP
work_nlc445pqs5hzxelntsxu5niqrq	70	3	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	70	4	Watters	Watters	NNP
work_nlc445pqs5hzxelntsxu5niqrq	70	5	GV	GV	NNP
work_nlc445pqs5hzxelntsxu5niqrq	70	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	70	7	Andermann	Andermann	NNP
work_nlc445pqs5hzxelntsxu5niqrq	70	8	E	E	NNP
work_nlc445pqs5hzxelntsxu5niqrq	70	9	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	70	10	et	et	NNP
work_nlc445pqs5hzxelntsxu5niqrq	70	11	al	al	NNP
work_nlc445pqs5hzxelntsxu5niqrq	70	12	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	71	1	Encephalitis	encephalitis	RB
work_nlc445pqs5hzxelntsxu5niqrq	71	2	among	among	IN
work_nlc445pqs5hzxelntsxu5niqrq	71	3	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	71	4	children	child	NNS
work_nlc445pqs5hzxelntsxu5niqrq	71	5	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	71	6	Northern	Northern	NNP
work_nlc445pqs5hzxelntsxu5niqrq	71	7	Quebec	Quebec	NNP
work_nlc445pqs5hzxelntsxu5niqrq	71	8	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	72	1	Ann	Ann	NNP
work_nlc445pqs5hzxelntsxu5niqrq	72	2	Neurol	Neurol	NNP
work_nlc445pqs5hzxelntsxu5niqrq	72	3	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	73	1	1988;24(4	1988;24(4	LS
work_nlc445pqs5hzxelntsxu5niqrq	73	2	)	)	-RRB-
work_nlc445pqs5hzxelntsxu5niqrq	73	3	:	:	:
work_nlc445pqs5hzxelntsxu5niqrq	73	4	483	483	CD
work_nlc445pqs5hzxelntsxu5niqrq	73	5	-	-	SYM
work_nlc445pqs5hzxelntsxu5niqrq	73	6	9	9	CD
work_nlc445pqs5hzxelntsxu5niqrq	73	7	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	74	1	2	2	LS
work_nlc445pqs5hzxelntsxu5niqrq	74	2	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	75	1	Crow	crow	VB
work_nlc445pqs5hzxelntsxu5niqrq	75	2	YJ	YJ	NNP
work_nlc445pqs5hzxelntsxu5niqrq	75	3	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	75	4	Black	Black	NNP
work_nlc445pqs5hzxelntsxu5niqrq	75	5	DN	DN	NNP
work_nlc445pqs5hzxelntsxu5niqrq	75	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	75	7	Ali	Ali	NNP
work_nlc445pqs5hzxelntsxu5niqrq	75	8	M	M	NNP
work_nlc445pqs5hzxelntsxu5niqrq	75	9	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	75	10	et	et	NNP
work_nlc445pqs5hzxelntsxu5niqrq	75	11	al	al	NNP
work_nlc445pqs5hzxelntsxu5niqrq	75	12	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	76	1	Cree	Cree	NNP
work_nlc445pqs5hzxelntsxu5niqrq	76	2	encephalitis	encephalitis	NNP
work_nlc445pqs5hzxelntsxu5niqrq	76	3	is	be	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	76	4	allelic	allelic	JJ
work_nlc445pqs5hzxelntsxu5niqrq	76	5	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	76	6	Aicardi	Aicardi	NNP
work_nlc445pqs5hzxelntsxu5niqrq	76	7	–	–	:
work_nlc445pqs5hzxelntsxu5niqrq	76	8	Goutières	Goutières	NNP
work_nlc445pqs5hzxelntsxu5niqrq	76	9	syndrome	syndrome	NN
work_nlc445pqs5hzxelntsxu5niqrq	76	10	:	:	:
work_nlc445pqs5hzxelntsxu5niqrq	76	11	implications	implication	NNS
work_nlc445pqs5hzxelntsxu5niqrq	76	12	for	for	IN
work_nlc445pqs5hzxelntsxu5niqrq	76	13	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	76	14	pathogenesis	pathogenesis	NN
work_nlc445pqs5hzxelntsxu5niqrq	76	15	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	76	16	disorders	disorder	NNS
work_nlc445pqs5hzxelntsxu5niqrq	76	17	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	76	18	interferon	interferon	NNP
work_nlc445pqs5hzxelntsxu5niqrq	76	19	alpha	alpha	NN
work_nlc445pqs5hzxelntsxu5niqrq	76	20	metabolism	metabolism	NN
work_nlc445pqs5hzxelntsxu5niqrq	76	21	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	77	1	J	J	NNP
work_nlc445pqs5hzxelntsxu5niqrq	77	2	Med	Med	NNP
work_nlc445pqs5hzxelntsxu5niqrq	77	3	Genet	Genet	NNP
work_nlc445pqs5hzxelntsxu5niqrq	77	4	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	78	1	2003	2003	CD
work_nlc445pqs5hzxelntsxu5niqrq	78	2	;	;	:
work_nlc445pqs5hzxelntsxu5niqrq	78	3	40(3):183	40(3):183	CD
work_nlc445pqs5hzxelntsxu5niqrq	78	4	-	-	SYM
work_nlc445pqs5hzxelntsxu5niqrq	78	5	7	7	CD
work_nlc445pqs5hzxelntsxu5niqrq	78	6	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	79	1	3	3	LS
work_nlc445pqs5hzxelntsxu5niqrq	79	2	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	80	1	Rice	Rice	NNP
work_nlc445pqs5hzxelntsxu5niqrq	80	2	GI	GI	NNP
work_nlc445pqs5hzxelntsxu5niqrq	80	3	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	80	4	Bond	Bond	NNP
work_nlc445pqs5hzxelntsxu5niqrq	80	5	J	J	NNP
work_nlc445pqs5hzxelntsxu5niqrq	80	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	80	7	Asipu	Asipu	NNP
work_nlc445pqs5hzxelntsxu5niqrq	80	8	A	A	NNP
work_nlc445pqs5hzxelntsxu5niqrq	80	9	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	80	10	et	et	NNP
work_nlc445pqs5hzxelntsxu5niqrq	80	11	al	al	NNP
work_nlc445pqs5hzxelntsxu5niqrq	80	12	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	81	1	Mutations	mutation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	81	2	involved	involve	VBN
work_nlc445pqs5hzxelntsxu5niqrq	81	3	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	81	4	Aicardi	Aicardi	NNP
work_nlc445pqs5hzxelntsxu5niqrq	81	5	–	–	:
work_nlc445pqs5hzxelntsxu5niqrq	81	6	Goutières	Goutières	NNP
work_nlc445pqs5hzxelntsxu5niqrq	81	7	syndrome	syndrome	NN
work_nlc445pqs5hzxelntsxu5niqrq	81	8	implicate	implicate	VBP
work_nlc445pqs5hzxelntsxu5niqrq	81	9	SAMHD1	SAMHD1	NNP
work_nlc445pqs5hzxelntsxu5niqrq	81	10	as	as	IN
work_nlc445pqs5hzxelntsxu5niqrq	81	11	regulator	regulator	NN
work_nlc445pqs5hzxelntsxu5niqrq	81	12	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	81	13	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	81	14	innate	innate	JJ
work_nlc445pqs5hzxelntsxu5niqrq	81	15	immune	immune	JJ
work_nlc445pqs5hzxelntsxu5niqrq	81	16	response	response	NN
work_nlc445pqs5hzxelntsxu5niqrq	81	17	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	82	1	Nat	Nat	NNP
work_nlc445pqs5hzxelntsxu5niqrq	82	2	Genet	Genet	NNP
work_nlc445pqs5hzxelntsxu5niqrq	82	3	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	83	1	2009;41(7):829	2009;41(7):829	CD
work_nlc445pqs5hzxelntsxu5niqrq	83	2	-	-	SYM
work_nlc445pqs5hzxelntsxu5niqrq	83	3	32	32	CD
work_nlc445pqs5hzxelntsxu5niqrq	83	4	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	84	1	4	4	LS
work_nlc445pqs5hzxelntsxu5niqrq	84	2	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	85	1	Crow	crow	VB
work_nlc445pqs5hzxelntsxu5niqrq	85	2	YJ	YJ	NNP
work_nlc445pqs5hzxelntsxu5niqrq	85	3	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	85	4	Chase	Chase	NNP
work_nlc445pqs5hzxelntsxu5niqrq	85	5	DS	DS	NNP
work_nlc445pqs5hzxelntsxu5niqrq	85	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	85	7	Lowenstein	Lowenstein	NNP
work_nlc445pqs5hzxelntsxu5niqrq	85	8	Schmidt	Schmidt	NNP
work_nlc445pqs5hzxelntsxu5niqrq	85	9	J	J	NNP
work_nlc445pqs5hzxelntsxu5niqrq	85	10	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	85	11	et	et	NNP
work_nlc445pqs5hzxelntsxu5niqrq	85	12	al	al	NNP
work_nlc445pqs5hzxelntsxu5niqrq	85	13	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	86	1	Characterization	characterization	NN
work_nlc445pqs5hzxelntsxu5niqrq	86	2	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	86	3	human	human	JJ
work_nlc445pqs5hzxelntsxu5niqrq	86	4	disease	disease	NN
work_nlc445pqs5hzxelntsxu5niqrq	86	5	phenotypes	phenotype	NNS
work_nlc445pqs5hzxelntsxu5niqrq	86	6	associated	associate	VBN
work_nlc445pqs5hzxelntsxu5niqrq	86	7	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	86	8	mutations	mutation	NNS
work_nlc445pqs5hzxelntsxu5niqrq	86	9	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	86	10	TREX1	TREX1	NNP
work_nlc445pqs5hzxelntsxu5niqrq	86	11	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	86	12	RNASEH2A	RNASEH2A	NNP
work_nlc445pqs5hzxelntsxu5niqrq	86	13	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	86	14	RNASEH2B	RNASEH2B	NNP
work_nlc445pqs5hzxelntsxu5niqrq	86	15	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	86	16	RNASEH2C	RNASEH2C	NNP
work_nlc445pqs5hzxelntsxu5niqrq	86	17	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	86	18	SAMHD1	SAMHD1	NNP
work_nlc445pqs5hzxelntsxu5niqrq	86	19	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	86	20	ADAR	ADAR	NNP
work_nlc445pqs5hzxelntsxu5niqrq	86	21	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	86	22	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	86	23	IFIH1	ifih1	PRP
work_nlc445pqs5hzxelntsxu5niqrq	86	24	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	87	1	Am	be	VBP
work_nlc445pqs5hzxelntsxu5niqrq	87	2	J	J	NNP
work_nlc445pqs5hzxelntsxu5niqrq	87	3	Med	Med	NNP
work_nlc445pqs5hzxelntsxu5niqrq	87	4	Genet	Genet	NNP
work_nlc445pqs5hzxelntsxu5niqrq	87	5	A.	a.	NN
work_nlc445pqs5hzxelntsxu5niqrq	88	1	2015;167A(2):296	2015;167A(2):296	NNP
work_nlc445pqs5hzxelntsxu5niqrq	88	2	-	-	SYM
work_nlc445pqs5hzxelntsxu5niqrq	88	3	312	312	CD
work_nlc445pqs5hzxelntsxu5niqrq	88	4	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	89	1	5	5	CD
work_nlc445pqs5hzxelntsxu5niqrq	89	2	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	90	1	Xin	Xin	NNP
work_nlc445pqs5hzxelntsxu5niqrq	90	2	B	B	NNP
work_nlc445pqs5hzxelntsxu5niqrq	90	3	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	90	4	Jones	Jones	NNP
work_nlc445pqs5hzxelntsxu5niqrq	90	5	S	S	NNP
work_nlc445pqs5hzxelntsxu5niqrq	90	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	90	7	Puffenberger	Puffenberger	NNP
work_nlc445pqs5hzxelntsxu5niqrq	90	8	EG	EG	NNP
work_nlc445pqs5hzxelntsxu5niqrq	90	9	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	90	10	et	et	NNP
work_nlc445pqs5hzxelntsxu5niqrq	90	11	al	al	NNP
work_nlc445pqs5hzxelntsxu5niqrq	90	12	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	91	1	Homozygous	homozygous	JJ
work_nlc445pqs5hzxelntsxu5niqrq	91	2	mutation	mutation	NN
work_nlc445pqs5hzxelntsxu5niqrq	91	3	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	91	4	SAMHD1	SAMHD1	NNP
work_nlc445pqs5hzxelntsxu5niqrq	91	5	gene	gene	NN
work_nlc445pqs5hzxelntsxu5niqrq	91	6	causes	cause	VBZ
work_nlc445pqs5hzxelntsxu5niqrq	91	7	cerebral	cerebral	JJ
work_nlc445pqs5hzxelntsxu5niqrq	91	8	vasculopathy	vasculopathy	NNP
work_nlc445pqs5hzxelntsxu5niqrq	91	9	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	91	10	early	early	JJ
work_nlc445pqs5hzxelntsxu5niqrq	91	11	onset	onset	NN
work_nlc445pqs5hzxelntsxu5niqrq	91	12	stroke	stroke	NN
work_nlc445pqs5hzxelntsxu5niqrq	91	13	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	92	1	Proc	Proc	NNP
work_nlc445pqs5hzxelntsxu5niqrq	92	2	Natl	Natl	NNP
work_nlc445pqs5hzxelntsxu5niqrq	92	3	Acad	Acad	NNP
work_nlc445pqs5hzxelntsxu5niqrq	92	4	Sci	Sci	NNP
work_nlc445pqs5hzxelntsxu5niqrq	92	5	U	U	NNP
work_nlc445pqs5hzxelntsxu5niqrq	92	6	S	S	NNP
work_nlc445pqs5hzxelntsxu5niqrq	92	7	A.	a.	NN
work_nlc445pqs5hzxelntsxu5niqrq	93	1	2011;108(13):5372	2011;108(13):5372	CD
work_nlc445pqs5hzxelntsxu5niqrq	93	2	-	-	SYM
work_nlc445pqs5hzxelntsxu5niqrq	93	3	7	7	CD
work_nlc445pqs5hzxelntsxu5niqrq	93	4	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	94	1	6	6	CD
work_nlc445pqs5hzxelntsxu5niqrq	94	2	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	95	1	Straussberg	Straussberg	NNP
work_nlc445pqs5hzxelntsxu5niqrq	95	2	R	R	NNP
work_nlc445pqs5hzxelntsxu5niqrq	95	3	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	95	4	Marom	Marom	NNP
work_nlc445pqs5hzxelntsxu5niqrq	95	5	D	D	NNP
work_nlc445pqs5hzxelntsxu5niqrq	95	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	95	7	Sanado	Sanado	NNP
work_nlc445pqs5hzxelntsxu5niqrq	95	8	-	-	HYPH
work_nlc445pqs5hzxelntsxu5niqrq	95	9	Inbar	Inbar	NNP
work_nlc445pqs5hzxelntsxu5niqrq	95	10	E	E	NNP
work_nlc445pqs5hzxelntsxu5niqrq	95	11	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	95	12	et	et	NNP
work_nlc445pqs5hzxelntsxu5niqrq	95	13	al	al	NNP
work_nlc445pqs5hzxelntsxu5niqrq	95	14	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	96	1	A	a	DT
work_nlc445pqs5hzxelntsxu5niqrq	96	2	possible	possible	JJ
work_nlc445pqs5hzxelntsxu5niqrq	96	3	geno-	geno-	JJ
work_nlc445pqs5hzxelntsxu5niqrq	96	4	type	type	NN
work_nlc445pqs5hzxelntsxu5niqrq	96	5	–	–	:
work_nlc445pqs5hzxelntsxu5niqrq	96	6	phenotype	phenotype	NN
work_nlc445pqs5hzxelntsxu5niqrq	96	7	correlation	correlation	NN
work_nlc445pqs5hzxelntsxu5niqrq	96	8	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	96	9	Ashkenazi	ashkenazi	JJ
work_nlc445pqs5hzxelntsxu5niqrq	96	10	Jewish	jewish	JJ
work_nlc445pqs5hzxelntsxu5niqrq	96	11	individuals	individual	NNS
work_nlc445pqs5hzxelntsxu5niqrq	96	12	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	96	13	Aicardi	Aicardi	NNP
work_nlc445pqs5hzxelntsxu5niqrq	96	14	–	–	:
work_nlc445pqs5hzxelntsxu5niqrq	96	15	Goutières	Goutières	NNP
work_nlc445pqs5hzxelntsxu5niqrq	96	16	syndrome	syndrome	NN
work_nlc445pqs5hzxelntsxu5niqrq	96	17	associated	associate	VBN
work_nlc445pqs5hzxelntsxu5niqrq	96	18	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	96	19	SAMHD1	SAMHD1	NNP
work_nlc445pqs5hzxelntsxu5niqrq	96	20	mutation	mutation	NN
work_nlc445pqs5hzxelntsxu5niqrq	96	21	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	97	1	J	J	NNP
work_nlc445pqs5hzxelntsxu5niqrq	97	2	Child	Child	NNP
work_nlc445pqs5hzxelntsxu5niqrq	97	3	Neurol	Neurol	NNP
work_nlc445pqs5hzxelntsxu5niqrq	97	4	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	98	1	2015;30(4):490	2015;30(4):490	CD
work_nlc445pqs5hzxelntsxu5niqrq	98	2	-	-	SYM
work_nlc445pqs5hzxelntsxu5niqrq	98	3	5	5	CD
work_nlc445pqs5hzxelntsxu5niqrq	98	4	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	99	1	7	7	LS
work_nlc445pqs5hzxelntsxu5niqrq	99	2	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	100	1	Ramesh	Ramesh	NNP
work_nlc445pqs5hzxelntsxu5niqrq	100	2	V	V	NNP
work_nlc445pqs5hzxelntsxu5niqrq	100	3	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	100	4	Bernardi	Bernardi	NNP
work_nlc445pqs5hzxelntsxu5niqrq	100	5	B	B	NNP
work_nlc445pqs5hzxelntsxu5niqrq	100	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	100	7	Stafa	Stafa	NNP
work_nlc445pqs5hzxelntsxu5niqrq	100	8	A	A	NNP
work_nlc445pqs5hzxelntsxu5niqrq	100	9	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	100	10	et	et	NNP
work_nlc445pqs5hzxelntsxu5niqrq	100	11	al	al	NNP
work_nlc445pqs5hzxelntsxu5niqrq	100	12	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	101	1	Intracerebral	intracerebral	JJ
work_nlc445pqs5hzxelntsxu5niqrq	101	2	large	large	JJ
work_nlc445pqs5hzxelntsxu5niqrq	101	3	artery	artery	NN
work_nlc445pqs5hzxelntsxu5niqrq	101	4	disease	disease	NN
work_nlc445pqs5hzxelntsxu5niqrq	101	5	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	101	6	Aicardi	Aicardi	NNP
work_nlc445pqs5hzxelntsxu5niqrq	101	7	–	–	:
work_nlc445pqs5hzxelntsxu5niqrq	101	8	Goutières	Goutières	NNP
work_nlc445pqs5hzxelntsxu5niqrq	101	9	syndrome	syndrome	NN
work_nlc445pqs5hzxelntsxu5niqrq	101	10	implicates	implicate	NNS
work_nlc445pqs5hzxelntsxu5niqrq	101	11	SAMHD1	SAMHD1	.
work_nlc445pqs5hzxelntsxu5niqrq	101	12	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	101	13	vascular	vascular	JJ
work_nlc445pqs5hzxelntsxu5niqrq	101	14	homeostasis	homeostasis	NN
work_nlc445pqs5hzxelntsxu5niqrq	101	15	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	102	1	Dev	Dev	NNP
work_nlc445pqs5hzxelntsxu5niqrq	102	2	Med	Med	NNP
work_nlc445pqs5hzxelntsxu5niqrq	102	3	Child	Child	NNP
work_nlc445pqs5hzxelntsxu5niqrq	102	4	Neurol	Neurol	NNP
work_nlc445pqs5hzxelntsxu5niqrq	102	5	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	103	1	2010;52(8):725	2010;52(8):725	CD
work_nlc445pqs5hzxelntsxu5niqrq	103	2	-	-	SYM
work_nlc445pqs5hzxelntsxu5niqrq	103	3	32	32	CD
work_nlc445pqs5hzxelntsxu5niqrq	103	4	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	104	1	8	8	LS
work_nlc445pqs5hzxelntsxu5niqrq	104	2	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	105	1	Lebon	Lebon	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	2	P	P	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	3	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	105	4	Badoual	Badoual	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	5	J	J	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	6	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	105	7	Ponsot	Ponsot	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	8	G	G	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	9	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	105	10	Goutières	Goutières	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	11	F	F	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	12	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	105	13	Hémeury	Hémeury	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	14	-	-	HYPH
work_nlc445pqs5hzxelntsxu5niqrq	105	15	Cukier	Cukier	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	16	F	F	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	17	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	105	18	Aicardi	Aicardi	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	19	J.	J.	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	20	Intrathecal	Intrathecal	NNP
work_nlc445pqs5hzxelntsxu5niqrq	105	21	synthesis	synthesis	NN
work_nlc445pqs5hzxelntsxu5niqrq	105	22	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	105	23	interferon	interferon	NN
work_nlc445pqs5hzxelntsxu5niqrq	105	24	-	-	HYPH
work_nlc445pqs5hzxelntsxu5niqrq	105	25	alpha	alpha	NN
work_nlc445pqs5hzxelntsxu5niqrq	105	26	in	in	IN
work_nlc445pqs5hzxelntsxu5niqrq	105	27	infants	infant	NNS
work_nlc445pqs5hzxelntsxu5niqrq	105	28	with	with	IN
work_nlc445pqs5hzxelntsxu5niqrq	105	29	progressive	progressive	JJ
work_nlc445pqs5hzxelntsxu5niqrq	105	30	familial	familial	JJ
work_nlc445pqs5hzxelntsxu5niqrq	105	31	encephalopathy	encephalopathy	NN
work_nlc445pqs5hzxelntsxu5niqrq	105	32	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	106	1	J	J	NNP
work_nlc445pqs5hzxelntsxu5niqrq	106	2	Neurol	Neurol	NNP
work_nlc445pqs5hzxelntsxu5niqrq	106	3	Sci	Sci	NNP
work_nlc445pqs5hzxelntsxu5niqrq	106	4	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	107	1	1988;84	1988;84	CD
work_nlc445pqs5hzxelntsxu5niqrq	107	2	(	(	-LRB-
work_nlc445pqs5hzxelntsxu5niqrq	107	3	2–3):201	2–3):201	CD
work_nlc445pqs5hzxelntsxu5niqrq	107	4	-	-	SYM
work_nlc445pqs5hzxelntsxu5niqrq	107	5	8	8	CD
work_nlc445pqs5hzxelntsxu5niqrq	107	6	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	108	1	LE	LE	NNP
work_nlc445pqs5hzxelntsxu5niqrq	108	2	JOURNAL	JOURNAL	NNP
work_nlc445pqs5hzxelntsxu5niqrq	108	3	CANADIEN	CANADIEN	NNP
work_nlc445pqs5hzxelntsxu5niqrq	108	4	DES	DES	NNP
work_nlc445pqs5hzxelntsxu5niqrq	108	5	SCIENCES	SCIENCES	NNP
work_nlc445pqs5hzxelntsxu5niqrq	108	6	NEUROLOGIQUES	NEUROLOGIQUES	NNP
work_nlc445pqs5hzxelntsxu5niqrq	108	7	Volume	Volume	NNP
work_nlc445pqs5hzxelntsxu5niqrq	108	8	44	44	CD
work_nlc445pqs5hzxelntsxu5niqrq	108	9	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	108	10	No	no	UH
work_nlc445pqs5hzxelntsxu5niqrq	108	11	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	109	1	6	6	LS
work_nlc445pqs5hzxelntsxu5niqrq	109	2	–	–	:
work_nlc445pqs5hzxelntsxu5niqrq	109	3	November	November	NNP
work_nlc445pqs5hzxelntsxu5niqrq	109	4	2017	2017	CD
work_nlc445pqs5hzxelntsxu5niqrq	109	5	751	751	CD
work_nlc445pqs5hzxelntsxu5niqrq	109	6	https://www.cambridge.org/core/terms	https://www.cambridge.org/core/term	NNS
work_nlc445pqs5hzxelntsxu5niqrq	109	7	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	110	1	https://doi.org/10.1017/cjn.2017.226	https://doi.org/10.1017/cjn.2017.226	NNP
work_nlc445pqs5hzxelntsxu5niqrq	110	2	Downloaded	download	VBN
work_nlc445pqs5hzxelntsxu5niqrq	110	3	from	from	IN
work_nlc445pqs5hzxelntsxu5niqrq	110	4	https://www.cambridge.org/core	https://www.cambridge.org/core	ADD
work_nlc445pqs5hzxelntsxu5niqrq	110	5	.	.	.
work_nlc445pqs5hzxelntsxu5niqrq	111	1	Carnegie	Carnegie	NNP
work_nlc445pqs5hzxelntsxu5niqrq	111	2	Mellon	Mellon	NNP
work_nlc445pqs5hzxelntsxu5niqrq	111	3	University	University	NNP
work_nlc445pqs5hzxelntsxu5niqrq	111	4	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	111	5	on	on	IN
work_nlc445pqs5hzxelntsxu5niqrq	111	6	06	06	CD
work_nlc445pqs5hzxelntsxu5niqrq	111	7	Apr	Apr	NNP
work_nlc445pqs5hzxelntsxu5niqrq	111	8	2021	2021	CD
work_nlc445pqs5hzxelntsxu5niqrq	111	9	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	111	10	01:38:33	01:38:33	CD
work_nlc445pqs5hzxelntsxu5niqrq	111	11	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	111	12	subject	subject	JJ
work_nlc445pqs5hzxelntsxu5niqrq	111	13	to	to	IN
work_nlc445pqs5hzxelntsxu5niqrq	111	14	the	the	DT
work_nlc445pqs5hzxelntsxu5niqrq	111	15	Cambridge	Cambridge	NNP
work_nlc445pqs5hzxelntsxu5niqrq	111	16	Core	Core	NNP
work_nlc445pqs5hzxelntsxu5niqrq	111	17	terms	term	NNS
work_nlc445pqs5hzxelntsxu5niqrq	111	18	of	of	IN
work_nlc445pqs5hzxelntsxu5niqrq	111	19	use	use	NN
work_nlc445pqs5hzxelntsxu5niqrq	111	20	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	111	21	available	available	JJ
work_nlc445pqs5hzxelntsxu5niqrq	111	22	at	at	IN
work_nlc445pqs5hzxelntsxu5niqrq	111	23	https://www.cambridge.org/core/terms	https://www.cambridge.org/core/terms	NNP
work_nlc445pqs5hzxelntsxu5niqrq	111	24	https://doi.org/10.1017/cjn.2017.226	https://doi.org/10.1017/cjn.2017.226	PRP
work_nlc445pqs5hzxelntsxu5niqrq	111	25	https://www.cambridge.org/core	https://www.cambridge.org/core	CD
work_nlc445pqs5hzxelntsxu5niqrq	111	26	Outline	outline	JJ
work_nlc445pqs5hzxelntsxu5niqrq	111	27	placeholder	placeholder	NN
work_nlc445pqs5hzxelntsxu5niqrq	111	28	Figure	figure	NN
work_nlc445pqs5hzxelntsxu5niqrq	111	29	1A	1A	VBG
work_nlc445pqs5hzxelntsxu5niqrq	111	30	through	through	IN
work_nlc445pqs5hzxelntsxu5niqrq	111	31	C	c	NN
work_nlc445pqs5hzxelntsxu5niqrq	111	32	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	111	33	age	age	NN
work_nlc445pqs5hzxelntsxu5niqrq	111	34	4	4	CD
work_nlc445pqs5hzxelntsxu5niqrq	111	35	months	month	NNS
work_nlc445pqs5hzxelntsxu5niqrq	111	36	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	111	37	T2W	t2w	NN
work_nlc445pqs5hzxelntsxu5niqrq	111	38	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	111	39	T2	T2	NNP
work_nlc445pqs5hzxelntsxu5niqrq	111	40	FLAIR	FLAIR	NNP
work_nlc445pqs5hzxelntsxu5niqrq	111	41	axial	axial	JJ
work_nlc445pqs5hzxelntsxu5niqrq	111	42	images	image	NNS
work_nlc445pqs5hzxelntsxu5niqrq	111	43	demonstrating	demonstrate	VBG
work_nlc445pqs5hzxelntsxu5niqrq	111	44	temporal	temporal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	111	45	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	111	46	frontal	frontal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	111	47	cysts	cyst	NNS
work_nlc445pqs5hzxelntsxu5niqrq	111	48	;	;	:
work_nlc445pqs5hzxelntsxu5niqrq	111	49	D	d	NN
work_nlc445pqs5hzxelntsxu5niqrq	111	50	through	through	IN
work_nlc445pqs5hzxelntsxu5niqrq	111	51	F	F	NNP
work_nlc445pqs5hzxelntsxu5niqrq	111	52	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	111	53	age	age	NN
work_nlc445pqs5hzxelntsxu5niqrq	111	54	11	11	CD
work_nlc445pqs5hzxelntsxu5niqrq	111	55	months	month	NNS
work_nlc445pqs5hzxelntsxu5niqrq	111	56	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	111	57	T2W	t2w	NN
work_nlc445pqs5hzxelntsxu5niqrq	111	58	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	111	59	T2	T2	NNP
work_nlc445pqs5hzxelntsxu5niqrq	111	60	FLAIR	FLAIR	NNP
work_nlc445pqs5hzxelntsxu5niqrq	111	61	axial	axial	JJ
work_nlc445pqs5hzxelntsxu5niqrq	111	62	images	image	NNS
work_nlc445pqs5hzxelntsxu5niqrq	111	63	demonstrating	demonstrate	VBG
work_nlc445pqs5hzxelntsxu5niqrq	111	64	temporal	temporal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	111	65	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	111	66	frontal	frontal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	111	67	cysts	cyst	NNS
work_nlc445pqs5hzxelntsxu5niqrq	111	68	and	and	CC
work_nlc445pqs5hzxelntsxu5niqrq	111	69	abnormal	abnormal	JJ
work_nlc445pqs5hzxelntsxu5niqrq	111	70	myelination	myelination	NN
work_nlc445pqs5hzxelntsxu5niqrq	111	71	status	status	NN
work_nlc445pqs5hzxelntsxu5niqrq	111	72	;	;	:
work_nlc445pqs5hzxelntsxu5niqrq	111	73	G	g	NN
work_nlc445pqs5hzxelntsxu5niqrq	111	74	,	,	,
work_nlc445pqs5hzxelntsxu5niqrq	111	75	age	age	NN
work_nlc445pqs5hzxelntsxu5niqrq	111	76	18	18	CD
work_nlc445pqs5hzxelntsxu5niqrq	111	77	months	month	NNS